<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">104909</article-id>
<article-id pub-id-type="doi">10.7554/eLife.104909</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.104909.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.2</article-version>
</article-version-alternatives>
<article-categories><subj-group subj-group-type="heading">
<subject>Biochemistry and Chemical Biology</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Structural Biology and Molecular Biophysics</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Structure of METTL3-METTL14 with an m6A nucleotide reveals insights into m6A conversion and sensing</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0175-6267</contrib-id>
<name>
<surname>Qi</surname>
<given-names>Shan</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kumar</surname>
<given-names>Abhay</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<ext-link ext-link-type="uri" xlink:href="https://www.researchsquare.com/article/rs-3150186/v1">https://www.researchsquare.com/article/rs-3150186/v1</ext-link>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Shuang</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhou</surname>
<given-names>Shuo</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Parihar</surname>
<given-names>Manish</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Villalobos</surname>
<given-names>Carmen</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gupta</surname>
<given-names>Navom</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chan</surname>
<given-names>Siu-Hong</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rao</surname>
<given-names>Manjeet K</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McHardy</surname>
<given-names>Stanton F</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Haider</surname>
<given-names>Shozeb</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6372-5007</contrib-id>
<name>
<surname>Gupta</surname>
<given-names>Yogesh K</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<email xlink:href="mailto:guptay@uthscsa.edu">guptay@uthscsa.edu</email>
</contrib>
<aff id="A1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02f6dcw23</institution-id><institution>Greehey Children’s Cancer Research Institute, University of Texas Health Science Center at San Antonio</institution></institution-wrap>, <city>San Antonio</city>, <country country="US">United States</country></aff>
<aff id="A2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02f6dcw23</institution-id><institution>Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio</institution></institution-wrap>, <city>San Antonio</city>, <country country="US">United States</country></aff>
<aff id="A3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jx3x895</institution-id><institution>Department of Pharmaceutical and Biological Chemistry, School of Pharmacy, University College London</institution></institution-wrap>, <city>London</city>, <country country="GB">United Kingdom</country></aff>
<aff id="A4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04ywg3445</institution-id><institution>New England Biolabs</institution></institution-wrap>, <city>Ipswich</city>, <country country="US">United States</country></aff>
<aff id="A5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01kd65564</institution-id><institution>Center for Innovative Drug Discovery, Department of Chemistry, University of Texas at San Antonio</institution></institution-wrap>, <city>San Antonio</city>, <country country="US">United States</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Roche</surname>
<given-names>Julien</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/04rswrd78</institution-id><institution>Iowa State University</institution>
</institution-wrap>
<city>Ames</city>
<country>United States of America</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Andreotti</surname>
<given-names>Amy H</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/04rswrd78</institution-id><institution>Iowa State University</institution>
</institution-wrap>
<city>Ames</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<fn fn-type="coi-statement">
<p>Competing Interest Statement: Y.K.G is the founder of Atomic Therapeutics. S-H.C. is an employee of New England Biolabs. These affiliations do not affect the authors’s impartiality and adherence to the journal’s standards.</p>
</fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2025-02-11">
<day>11</day>
<month>02</month>
<year>2025</year>
</pub-date>
<volume>14</volume>
<elocation-id>RP104909</elocation-id>
<history><date date-type="sent-for-review" iso-8601-date="2024-11-25">
<day>25</day>
<month>11</month>
<year>2024</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2024-10-23">
<day>23</day>
<month>10</month>
<year>2024</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.21203/rs.3.rs-3150186/v2"/>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2025, Qi et al</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Qi et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-104909-v1.pdf"/>
<abstract>
<title>Abstract</title>
<p>The nuclear METTL3-METTL14 transfers a methyl group from SAM to convert the <italic>N<sup>6</sup></italic> of adenosine (A) in RNA to m<sup>6</sup>A and in ssDNA to 6mA. m<sup>6</sup>A marks are prevalent in eukaryotic mRNAs and lncRNAs and modulate their stability and fate in a context-dependent manner. The cytoplasmic METTL3 can act as a m<sup>6</sup>A reader. However, the precise mechanism during m6A writing, reading, or sensing is unclear. Here, we present a ~2.5 Å structure of the methyltransferase core of human METTL3-METTL14 in complex with the reaction product mimic, <italic>N<sup>6</sup></italic>-methyladenosine monophosphate (m<sup>6</sup>A), representing a state post-catalysis but before the release of m<sup>6</sup>A. m<sup>6</sup>A occupies an evolutionarily conserved RNA-binding pocket ~16 Å away from the SAM pocket that also frequently mutates in cancer. We propose a two-step model of <italic>swiveling</italic> of target A upon conversion to m<sup>6</sup>A and <italic>sensing</italic> its methylation status by this pocket, enabling it to actuate enzymes’ switch from writer to an m<sup>6</sup>A-sensor. Cancer-associated mutations show impaired RNA binding dynamics, de-stacking, and defective m<sup>6</sup>A writing and sensing.</p>
</abstract>
<kwd-group>
<kwd>RNA modifications</kwd>
<kwd>m6A</kwd>
<kwd>Enzyme mechanisms</kwd>
<kwd>X-ray crystallography</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta specific-use="meta-only">
<meta-name>publishing-route</meta-name>
<meta-value>prc</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>A heterodimer of Methyltransferase like-3 (METTL3) and its obligate partner METTL14 installs the majority of m<sup>6</sup>A (<italic>N<sup>6</sup></italic>-methyladenosine) modification within the consensus DR<underline>A</underline>CH (D=A/G/U, R=A/G, H=A/C/U) motif in eukaryotic mRNAs and lncRNAs<sup><xref ref-type="bibr" rid="ref1">1</xref>–<xref ref-type="bibr" rid="ref5">5</xref></sup>, chromosome-associated regulatory RNAs (carRNAs)<sup><xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref7">7</xref></sup>, and 7SK RNA<sup><xref ref-type="bibr" rid="ref8">8</xref></sup>. METTL3 and METTL14 contain an MT-A70 family methyltransferase (MTase) core<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> diverged from an ancestral β-class of bacterial MTases<sup><xref ref-type="bibr" rid="ref10">10</xref>–<xref ref-type="bibr" rid="ref13">13</xref></sup>. METTL3 hydrolyzes SAM to facilitate the transfer of its methyl group to the <italic>N<sup>6</sup></italic> amino group of the target adenine base in RNA <italic>(in vivo</italic> and <italic>in vitro</italic>)<sup><xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref9">9</xref></sup> and ssDNA (<italic>in vitro</italic>)<sup><xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref12">12</xref></sup>. In contrast, catalytically deficient METTL14 stabilizes METTL3 and is thought to position RNA in METTL3’s active site<sup><xref ref-type="bibr" rid="ref14">14</xref>–<xref ref-type="bibr" rid="ref17">17</xref></sup>. m<sup>6</sup>A modifications modulate RNA stability and play essential roles in myriad biological processes, including but not limited to miRNA biogenesis, maintenance of neural stem cells, translation efficiency, transcription elongation, innate immune response, DNA break repair, circadian rhythm, and viral pathogenesis<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup>. Consistently, severe growth defects observed in the cellular KO phenotype of METTL3 underscore METTL3’s essential role in maintaining cellular homeostasis during development<sup><xref ref-type="bibr" rid="ref20">20</xref>–<xref ref-type="bibr" rid="ref22">22</xref></sup>, cancer growth<sup><xref ref-type="bibr" rid="ref23">23</xref>–<xref ref-type="bibr" rid="ref26">26</xref></sup>, and viral infections, including SARS-CoV-2<sup><xref ref-type="bibr" rid="ref27">27</xref>–<xref ref-type="bibr" rid="ref29">29</xref></sup>.</p>
<p>While m<sup>6</sup>A deposition in mRNAs occurs in the nucleus and elevated METTL3 levels are associated with survival of acute myeloid leukemia<sup><xref ref-type="bibr" rid="ref24">24</xref>,<xref ref-type="bibr" rid="ref30">30</xref></sup>, non-catalytic functions of METTL3 outside the nucleus benefit lung cancer cells<sup><xref ref-type="bibr" rid="ref23">23</xref>,<xref ref-type="bibr" rid="ref25">25</xref></sup>. Cytoplasmic METTL3 can act as an m<sup>6</sup>A reader to promote the translation of mRNA of known oncogenes, thereby facilitating the crosstalk between m<sup>6</sup>A-bound METTL3 at 3’-end to the translation initiation machinery that has engaged the 5’- mRNA cap<sup><xref ref-type="bibr" rid="ref23">23</xref>,<xref ref-type="bibr" rid="ref25">25</xref>,<xref ref-type="bibr" rid="ref31">31</xref></sup>.</p>
<p>m<sup>6</sup>A marks are also present in genomes of RNA viruses such as hepatitis C, Zika, dengue, West Nile, yellow fever, and SARS-CoV-2, and modulate viral replication and host immune response<sup><xref ref-type="bibr" rid="ref27">27</xref></sup>. Thus, METTL3 has emerged as an attractive drug target for anti-cancer and anti-viral therapy development. Consistently, pharmacologic inhibition of METTL3 limits the growth of acute myeloid leukemia<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> and SARS-CoV-2<sup><xref ref-type="bibr" rid="ref28">28</xref>,<xref ref-type="bibr" rid="ref29">29</xref></sup>. The first METTL3 inhibitor STC-15 that targets its SAM pocket has entered Phase I clinical trial (NCT05584111).</p>
<p>Despite significant advancement in the m<sup>6</sup>A field and interest in targeting it for therapy, the structural details of RNA recognition and catalysis by METTL3-METTL14 are lacking. Here we present a ~2.5 Å crystal structure of the methyltransferase core of METTL3-METTL14 bound to methyladenosine monophosphate (m<sup>6</sup>A), a product mimic of the methylation reaction (<xref ref-type="fig" rid="fig1">Fig. 1a</xref>). We show that m<sup>6</sup>A occupies a novel cryptic pocket constituted to a large extent by residues from METTL3 and an interface arginine (R298) of METTL14. This pocket is evolutionarily conserved in mammals, plants, and yeast (<xref ref-type="fig" rid="fig1">Fig. 1b</xref>). Importantly, residues that partake in interaction with m<sup>6</sup>A are mutated in gynecologic, stomach, kidney, and bladder cancers<sup><xref ref-type="bibr" rid="ref32">32</xref></sup> (<xref ref-type="fig" rid="fig1">Fig. 1b</xref>). When introduced into wild-type METTL3-METTL14, the mutant enzymes exhibit a significant loss in catalysis, perturbed RNA binding, and compromised ability of de-stacking of the target adenine for presentation to the active site. Our data suggest that the target base swivels ~120º after methylation for sensing by the cryptic pocket located ~16 Å away from the point of methyl transfer. METTL3-METTL14 uses this unique mechanism to sense the methylation status before releasing the substrate RNA. This arrangement will require de-stacking of the target base during catalysis and sensing. We also show that the wild-type METTL3-METTL14, but not the mutant, binds more tightly to an m<sup>6</sup>A-modified RNA to distinguish it from the unmethylated RNA. Moreover, the enzyme harboring R298P mutation, the most frequent mutation in endometrial cancer<sup><xref ref-type="bibr" rid="ref32">32</xref></sup>, exhibits sub-optimal RNA binding, catalysis, and base de-stacking ability. Our results uncover entirely unexpected operating principles underlying methyl transfer and m<sup>6</sup>A-sensing by METTL3-METTL14.</p>
<fig id="fig1" position="float" fig-type="figure">
<label>Figure 1</label>
<caption><title>Structure of m<sup>6</sup>A bound human METTL3-METTL14 MTase core.</title>
<p><bold>a,</bold> Domain architecture of METTL3 and METTL14; and boundaries of each used in crystallization are shown on top. Structure of the complex is shown in cartoon mode for METTL3 in cyan and METTL14 in orange; m6AMP (red) and interacting residues of METTL3 (green) and METTL14 (orange) are shown in stick mode. Blue dot, the position of <italic>N<sup>6</sup></italic> (in acceptor mode), i.e., ~3Å from the methyl group of the donor SAM. Methylated <italic>N<sup>6</sup></italic> of m<sup>6</sup>A is ~16Å away from its acceptor position in the catalytic pocket (blue dot). Black dots, water. Black dashes, h-bonds. The panel on right shows a close-up of the m<sup>6</sup>A interaction network, including the <italic>arginine clasp.</italic> <bold>b,</bold> An alignment of the regions participating in m<sup>6</sup>A confirms strict conservation of the interaction network throughout the evolution from yeast (Uniprot ID: P41833); arabidopsis (082486) and rice (Q6EU10); fruit fly (Q9VCE6), zebrafish (F1R777), mouse (Q8C3P7), hamster (A0A1U7R3Z3), and monkey (A0A8J8YGJ7); to human (Q86U44). <bold>c,</bold> Methyltransferase activity results of full-length human METTL3-METTL14 (wild-type, WT) and eight mutant enzymes as derived from three independent experiments, with error bars indicating the range of data points from these experiments (n = 3). <bold>d,</bold> Quantitative measurement of RNA (red, m<sup>6</sup>A-RNA; blue, A-RNA) binding (n = 3) by the WT enzyme shown as binding isotherms fitted with a one-site specific binding model. The equilibrium dissociation constant or <italic>K<sub>d</sub></italic> derived for each mutant enzyme is plotted along with <italic>K<sub>d</sub></italic> of the WT enzyme (<bold>e</bold>). ns, not significant (<italic>p</italic> &gt;0.05), * denotes <italic>p ≤</italic> 0.05. Source data for panels <bold>c-e</bold> are provided.</p></caption>
<graphic xlink:href="3150186v2_fig1.tif" mime-subtype="tif" mimetype="image"/>
</fig>
</sec>
<sec id="s2" sec-type="results|discussion">
<title>Results and discussion</title>
<sec id="s2-1">
<title>Overall structure</title>
<p>The MTase cores of human METTL3 (aa 358 - 580) and METTL14 (aa 116 - 378) form an obligate heterodimer. METTL3 acts as an active SAM-dependent MTase, whereas METTL14, an inactive MTase, stabilizes RNA<sup><xref ref-type="bibr" rid="ref14">14</xref>–<xref ref-type="bibr" rid="ref17">17</xref></sup>. We co-purified the MTase core of METTL3-METTL14 from <italic>E. coli.</italic> We succeeded in resolving its structure in the presence of <italic>N<sup>6</sup></italic>-methyladenosine 5’-monophosphate (m<sup>6</sup>AMP, referred to as m<sup>6</sup>A), a product of methylation reaction, by soaking m<sup>6</sup>A into apo crystals (<xref ref-type="fig" rid="fig1">Fig. 1 a</xref>, <xref ref-type="fig" rid="fig5">Extended data Fig. 1a-c</xref>). The difference omit map showed clear and unbiased electron density for m<sup>6</sup>A, which was refined well with no discrepancies for the ligand, surrounding regions, or the rest of the protein (<xref ref-type="fig" rid="fig5">Extended data Fig. 1d-g</xref> and <xref ref-type="table" rid="tbl4">table 1</xref>). METTL3-METTL14-m<sup>6</sup>A model was refined to ~2.5 Å resolution, with excellent stereochemistry and R<sub>free</sub> and R<sub>work</sub> of ~26.2 and 22.9%, respectively (<xref ref-type="table" rid="tbl4">Extended data Table 1</xref>). The final model contains one molecule each of METTL3 (aa 369 – 579), METTL14 (aa 116 – 402), one m<sup>6</sup>A, 90 water, and two ethylene glycol.</p>
<p>The overall fold of METTL3-METTL14 is similar to those reported previously<sup><xref ref-type="bibr" rid="ref14">14</xref>–<xref ref-type="bibr" rid="ref16">16</xref></sup>, except for notable changes in the region around the m<sup>6</sup>A binding pocket. MTases adopt a β-class of MTase fold with a central β-sheet of seven parallel and one antiparallel β-strands flanked by three helices on each side. Three major loops (gate loops 1 and 2 and an interface loop) emanating from the central β-sheet of METTL3 participate in SAM, RNA, and METTL14 binding. While the two gate loops exhibit high flexibility upon SAM or SAH binding and release, the interface loop remains rigid due to extensive protein-protein contacts from METTL14 MTase (<xref ref-type="fig" rid="fig1">Fig. 1a</xref>).</p>
<p>While the MTase core of METTL3-METTL14 is not catalytically active form, its structures derived by soaking SAM or SAH into these crystals provided crucial insights into the binding of methyl donor (SAM) and byproduct (SAH) and important conformational changes in the regions of METTL3 (gate loops 1, 2) surrounding these ligands<sup><xref ref-type="bibr" rid="ref14">14</xref>–<xref ref-type="bibr" rid="ref16">16</xref></sup>. The m6A-bound structure, which we report here, is the first nucleotide-bound form of the MTase core of METTL3-14 and provides crucial insights into the mechanism of this critical enzyme that is central to normal homeostasis and diseases. Since a small molecule targeting the catalytic pocket of METTL3 has entered human clinical trials for cancer therapy, our results showing the nucleotide binding in the regions outside of catalytic and SAM-binding pockets will pave the way for the rational design of more specific inhibitors.</p>
</sec>
<sec id="s2-2">
<title>Evolutionarily conserved m<sup>6</sup>A pocket plays an essential role in m<sup>6</sup>A sensing</title>
<p>Strikingly, m<sup>6</sup>A occupies a cryptic pocket ~16 Å away from the methyl donor SAM pocket with its <italic>N<sup>6</sup></italic>-methyl moiety in an energetically favored <italic>syn</italic> conformation, facing outward (<xref ref-type="fig" rid="fig1">Fig. 1a</xref>). Previously, this region was postulated to bind RNA due to its positive charge and polar nature<sup><xref ref-type="bibr" rid="ref14">14</xref>–<xref ref-type="bibr" rid="ref16">16</xref></sup>. m<sup>6</sup>A is stabilized by a vast network of specific interactions, mostly from METTL3 and R298 of METTL14. The purine ring of m<sup>6</sup>A is sandwiched between the side chain of M402 and the backbone atoms of the interface loop residues, R471, T472, G473, and H474. The two arginine residues (R471 of METTL3 and R298 of METTL14) act like a <italic>clasp</italic> to hold the <italic>N<sup>6</sup></italic>-methyl moiety in place through a direct h-bond between R298 and <italic>N<sup>1</sup></italic>, van der Waals and hydrophobic interactions between <italic>N<sup>6</sup></italic>-methyl and its aliphatic portion, and the amino group of the R471 side chain, respectively. The carbonyl oxygen of G473 appears to neutralize the positive charge of the R298 residue. The carbonyl moiety of R471 embraces the <italic>N<sup>6</sup></italic> atom of m<sup>6</sup>A via a direct h-bond, while the opposite side is stabilized by the side chain of H474 via a π-π interaction. Altogether, the <italic>arginine clasp</italic>, interface loop residues R471-H474 and M402, forms a partial closure around the methylated purine ring of m<sup>6</sup>A. The ribose in the C3’-endo conformation is stacked between the backbone atoms of G473 and H478 and the side chains of I400 and H478. The phosphate group of m<sup>6</sup>A is locked in place by multiple direct h-bonds with its phosphoryl oxygens and side chains of H478, E481, T433, and K459 (water-mediated) – all from METTL3, and another water-mediated interaction with E257 of METTL14. The side chain of H478 holds the m<sup>6</sup>A phosphate on one side and E257 of METTL14 on the other, thus acting as a hinge (<xref ref-type="fig" rid="fig1">Fig 1a</xref>, <xref ref-type="fig" rid="fig5">Extended data Fig. 1g</xref>).</p>
<p>Strict conservation of the extensive interaction network of m<sup>6</sup>A in human, animal, plant, and yeast suggests that m<sup>6</sup>A sensing by this cryptic pocket is an evolutionarily conserved mechanism (<xref ref-type="fig" rid="fig1">Fig. 1b</xref>). Several key residues that partake in m<sup>6</sup>A binding, such as R471 and R298 of the <italic>arginine clasp</italic>, E481, and H478 that stabilize the <italic>N<sup>6</sup></italic>-methyl and phosphate groups are recurrently mutated in endometrioid and adenocarcinoma<sup><xref ref-type="bibr" rid="ref32">32</xref></sup> (<xref ref-type="fig" rid="fig1">Fig. 1b</xref>). We introduced the R298P mutation in METTL14, a recurrent mutation event in endometrioid carcinoma<sup><xref ref-type="bibr" rid="ref32">32</xref>,<xref ref-type="bibr" rid="ref33">33</xref></sup>, and the R471H, E481A, T433A, K459A, and H478A mutations in METTL3. In addition, we generated two deletion mutants (Δ472-473, Δ472-474) in which three residues of METTL3 (T472, G473, H474) that stack against the purine ring of m<sup>6</sup>A were deleted to shorten the interface loop.</p>
<p>We co-purified the full-length wild-type human METTL3-METTL14 and eight mutant enzymes from insect cells and probed their RNA methylation and binding activities. We used a 30-mer RNA oligo (NEAT2*) consisting of one canonical GG<underline>AC</underline>U motif. Consistently, R298P and R471H mutants significantly reduced (up to 85%), whereas T433A resulted in ~20% loss in methyltransferase activity, agreeing with the reduced m<sup>6</sup>A levels observed in endometrial tumors harboring the R298P mutation<sup><xref ref-type="bibr" rid="ref33">33</xref></sup>. The other five mutations in METTL3 (Δ472-473, Δ472-474, K459A, E481A, and H478A) completely abolished the RNA methyltransferase activity of METTL3-METTL14 (<xref ref-type="fig" rid="fig1">Fig. 1c</xref>). Thus, the evolutionarily conserved m<sup>6</sup>A binding pocket is essential for efficient conversion of A to m<sup>6</sup>A.</p>
<p>Next, we quantitatively determined the binding affinities of wild-type (WT) and mutant enzymes to the substrate and a product RNA, wherein the target A base within GG<underline>A</underline>CU is replaced by m<sup>6</sup>A. We covalently attached a fluoresceine moiety to the 5’-end of both the substrate NEAT2* (A-RNA) and product (m<sup>6</sup>A-RNA) RNAs and performed fluorescence polarization-based assays. The WT enzyme can still bind the m<sup>6</sup>A-RNA and A-RNA with high affinity (<italic>K<sub>d</sub></italic> = 9-20 nM) (<xref ref-type="fig" rid="fig1">Fig. 1 d,e</xref>), corroborating previous studies attributing a sort of m<sup>6</sup>A-reader function to METTL3 <italic>in vivo</italic><sup><xref ref-type="bibr" rid="ref23">23</xref>,<xref ref-type="bibr" rid="ref25">25</xref>,<xref ref-type="bibr" rid="ref31">31</xref>,<xref ref-type="bibr" rid="ref34">34</xref></sup>. In contrast, the mutants, including R298P and R471H (both mutated in cancers and belong to the <italic>arginine clasp</italic> motif that stabilizes the m<sup>6</sup>A) exhibited a loss in binding affinity with varying degrees, with R298P showing weakest binding (<xref ref-type="fig" rid="fig1">Fig. 1e</xref>, <xref ref-type="fig" rid="fig5">Extended data Fig. 1h</xref>). Thus, inability to sense and distinguish m<sup>6</sup>A properly by the R298P mutation could result in total m6A and promote tumorigenicity and growth of endometrial tumors as observed previously<sup><xref ref-type="bibr" rid="ref33">33</xref></sup>. The nanomolar affinity observed in this fluorescence polarization (FP)-based assay for mutant enzymes suggests a significant contribution of accessory motifs such as zinc fingers (ZnFs) of METTL3 and RGG repeats of METTL14 to RNA binding, especially the predicted bulged stem-loop structure of NEAT2* RNA (A-RNA). These motifs are intact in both the wild-type and the mutant enzymes. This could be one of the reasons for not observing the radical change in overall RNA binding as measured by the equilibrium dissociation constant (Kd) for A vs. m6A RNA in an FP-based assay. Moreover, the residue aligning the catalytic and cryptic pockets would interact with the substrate (A) and the product (m6A) nucleotide of the ‘DR<bold>A</bold>CH’ sequence during the pivoting of the base upon conversion to m6A, respectively. Even if the mutations in the cryptic pocket retain overall RNA binding dominated by domains flanking the MTase core (ZnFs and RGG) and the secondary structure of RNA itself (GGACU containing stem-loop RNAs show higher affinity), they could still influence the pivoting of the m6A base and its release after conversion.</p>
<p>We also performed a kinetic analysis by varying the concentration range of RNA substrate from 10 nM to 10 μM in the presence of a saturating concentration of SAM (10 μM) (<xref ref-type="fig" rid="fig2">Fig. 2a</xref>). Consistently, these results show that the wild-type enzyme yields the highest methylation activity, whereas the mutant enzymes show reduced methylation. Next, we studied the binding kinetics of the full-length METTL3-METTL14, wild-type (WT), and the two mutant enzymes harboring R298P and R471H mutations in METTL14 and METTL3, respectively. We employed the surface plasmon resonance (SPR) technique, a gold standard for studying binding kinetics that includes ON (K<sub>on</sub>) and OFF (K<sub>off</sub>) rates of RNA binding. We used our original RNA substrate, NEAT2 (30-mer bulged stem-loop) RNA, and its methylated version (NEAT2-m6A). We also examined a 14-mer linear RNA substrate (r6T) and its methylated form (r6T-m6A) to fully understand the kinetics of enzyme binding to GGACU-containing RNAs with different shapes and sequences. The SPR data of the WT enzyme fit well with a 1:1 binding model. As shown in <xref ref-type="fig" rid="fig2">Fig. 2b</xref> and <xref ref-type="table" rid="tbl1">Tables 1</xref>-<xref ref-type="table" rid="tbl3">3</xref>, the binding affinity and kinetics of METTL3-METTL14 enzymes differ significantly on the two RNA oligos tested. The structured NEAT2 RNA shows a 5-fold tighter affinity than a linear r6T substrate, while their methylated counterparts show reduced binding (1.3-fold for NEAT2-m6A and 2.3-fold for r6T-m6A), but the Kds (dissociation constants) are still in sub and low-micromolar range.</p>
<fig id="fig2" position="float" fig-type="figure">
<label>Figure 2</label>
<caption><title>Enzyme and binding kinetics.</title>
<p><bold>a,</bold> Methylation of NEAT2* RNA by full-length METTL3-METTL14 (wild-type, WT and its mutants) at saturating concentrations of SAM and RNA. <bold>b-c,</bold> Kinetics of RNA binding to the WT and mutant METTL3-METTL14 as measured using surface plasmon resonance. Two RNA oligos (NEAT2* and a single-stranded RNA) comprising substrate A (grey circle) or product m6A (red circle) were probed.</p></caption>
<graphic xlink:href="3150186v2_fig2.tif" mime-subtype="tif" mimetype="image"/>
</fig>
<table-wrap id="tbl1" position="float" orientation="portrait">
<label>Table 1.</label>
<caption><title>Capture level of different RNA substrates</title></caption>
<alternatives>
<graphic xlink:href="3150186v2_tbl1.tif" mime-subtype="tif" mimetype="image"/>
<table frame="void" rules="rows">
<thead>
<tr>
<th align="left" valign="top">Flow cell</th>
<th align="left" valign="top">RNA substrate</th>
<th align="left" valign="top">Captured (RU)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="right" valign="top">3</td>
<td align="left" valign="top">rNEAT2</td>
<td align="left" valign="top">66.4</td>
</tr>
<tr>
<td align="right" valign="top">4</td>
<td align="left" valign="top">rNEAT2-m6A</td>
<td align="left" valign="top">62.7</td>
</tr>
<tr>
<td align="right" valign="top">5</td>
<td align="left" valign="top">r6T</td>
<td align="left" valign="top">48.9</td>
</tr>
<tr>
<td align="right" valign="top">6</td>
<td align="left" valign="top">r6T-m6A</td>
<td align="left" valign="top">51.2</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
<table-wrap id="tbl2" position="float" orientation="portrait">
<label>Table 2.</label>
<caption><title>Kinetic parameters for all evaluated bindings with 1:1 binding model</title></caption>
<alternatives>
<graphic xlink:href="3150186v2_tbl2.tif" mime-subtype="tif" mimetype="image"/>
<table frame="void" rules="rows">
<thead>
<tr>
<th align="left" valign="top">Ligand RNA</th>
<th align="left" valign="top">Analyte Protein</th>
<th align="left" valign="top">K<sub>on</sub> (10<sup>5</sup> M<sup>-1</sup> S<sup>-1</sup>)</th>
<th align="left" valign="top">K<sub>off</sub> (10<sup>-2</sup>S<sup>-1</sup>)</th>
<th align="left" valign="top">K<sub>D</sub> (nM)</th>
<th align="left" valign="top">Rmax (RU<sub>max</sub>)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="right" valign="top">rNEAT2</td>
<td align="left" valign="top">METTL3-METTL14</td>
<td align="left" valign="top">1.64</td>
<td align="left" valign="top">4.22</td>
<td align="left" valign="top">256</td>
<td align="left" valign="top">5.19×10<sup>2</sup></td>
</tr>
<tr>
<td align="right" valign="top">rNEAT2-m6A</td>
<td align="left" valign="top">METTL3- METTL14</td>
<td align="left" valign="top">0.755</td>
<td align="left" valign="top">2.55</td>
<td align="left" valign="top">337</td>
<td align="left" valign="top">4.50×10<sup>2</sup></td>
</tr>
<tr>
<td align="right" valign="top">r6T</td>
<td align="left" valign="top">METTL3- METTL14</td>
<td align="left" valign="top">0.855</td>
<td align="left" valign="top">11.6</td>
<td align="left" valign="top">1360</td>
<td align="left" valign="top">4.21×10<sup>2</sup></td>
</tr>
<tr>
<td align="right" valign="top">r6T-m6A</td>
<td align="left" valign="top">METTL3- METTL14</td>
<td align="left" valign="top">0.0774</td>
<td align="left" valign="top">24100</td>
<td align="left" valign="top">3120</td>
<td align="left" valign="top">5.55×10<sup>2</sup></td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
<table-wrap id="tbl3" position="float" orientation="portrait">
<label>Table 3.</label>
<caption><title>Kinetic parameters for all evaluated bindings with two state reaction model</title></caption>
<alternatives>
<graphic xlink:href="3150186v2_tbl3.tif" mime-subtype="tif" mimetype="image"/>
<table frame="void" rules="rows">
<thead>
<tr>
<th align="left" valign="top">Ligand RNA</th>
<th align="left" valign="top">Analyte Protein</th>
<th align="left" valign="top">K<sub>on1</sub> (M<sup>-1</sup> S<sup>-1</sup>)</th>
<th align="left" valign="top">K<sub>off1</sub> (S<sup>-1</sup>)</th>
<th align="left" valign="top">K<sub>on2</sub> (M<sup>-1</sup> S<sup>-1</sup>)</th>
<th align="left" valign="top">K<sub>off2</sub> (S<sup>-1</sup>)</th>
<th align="left" valign="top">K<sub>D</sub>(nM)</th>
<th align="left" valign="top">Rmax (RU<sub>max</sub>)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="right" valign="top" rowspan="2">rNEAT2</td>
<td align="left" valign="top">R471H</td>
<td align="left" valign="top">2.59×10<sup>4</sup></td>
<td align="left" valign="top">2.17×10<sup>-2</sup></td>
<td align="left" valign="top">6.02×10<sup>-3</sup></td>
<td align="left" valign="top">4.54×10<sup>-4</sup></td>
<td align="left" valign="top">58.8</td>
<td align="left" valign="top">6.97×10<sup>2</sup></td>
</tr>
<tr>
<td align="left" valign="top">R298P</td>
<td align="left" valign="top">2.93×10<sup>4</sup></td>
<td align="left" valign="top">2.28×10<sup>-2</sup></td>
<td align="left" valign="top">3.68×10<sup>-3</sup></td>
<td align="left" valign="top">3.11×10<sup>-3</sup></td>
<td align="left" valign="top">356</td>
<td align="left" valign="top">3.73×10<sup>2</sup></td>
</tr>
<tr>
<td align="right" valign="top" rowspan="2">rNEAT2-m6A</td>
<td align="left" valign="top">R471H</td>
<td align="left" valign="top">2.73×10<sup>4</sup></td>
<td align="left" valign="top">2.22×10<sup>-2</sup></td>
<td align="left" valign="top">5.82×10<sup>-3</sup></td>
<td align="left" valign="top">4.85×10<sup>-4</sup></td>
<td align="left" valign="top">62.8</td>
<td align="left" valign="top">5.03×10<sup>2</sup></td>
</tr>
<tr>
<td align="left" valign="top">R298P</td>
<td align="left" valign="top">2.38×10<sup>4</sup></td>
<td align="left" valign="top">2.77×10<sup>-2</sup></td>
<td align="left" valign="top">6.09×10<sup>-3</sup></td>
<td align="left" valign="top">5.23×10<sup>-3</sup></td>
<td align="left" valign="top">538</td>
<td align="left" valign="top">3.23×10<sup>2</sup></td>
</tr>
<tr>
<td align="right" valign="top" rowspan="2">r6T</td>
<td align="left" valign="top">R471H</td>
<td align="left" valign="top">4.43×10<sup>4</sup></td>
<td align="left" valign="top">3.85×10<sup>-2</sup></td>
<td align="left" valign="top">5.06×10<sup>-3</sup></td>
<td align="left" valign="top">7.21×10<sup>-4</sup></td>
<td align="left" valign="top">108</td>
<td align="left" valign="top">4.19×10<sup>2</sup></td>
</tr>
<tr>
<td align="left" valign="top">R298P</td>
<td align="left" valign="top">5.38×10<sup>3</sup></td>
<td align="left" valign="top">4.00×10<sup>-2</sup></td>
<td align="left" valign="top">2.14×10<sup>-3</sup></td>
<td align="left" valign="top">8.79×10<sup>-4</sup></td>
<td align="left" valign="top">2160</td>
<td align="left" valign="top">5.52×10<sup>2</sup></td>
</tr>
<tr>
<td align="right" valign="top" rowspan="2">r6T-m6A</td>
<td align="left" valign="top">R471H</td>
<td align="left" valign="top">6.87×10<sup>6</sup></td>
<td align="left" valign="top">8.99</td>
<td align="left" valign="top">6.74×10<sup>-3</sup></td>
<td align="left" valign="top">1.01×10<sup>-3</sup></td>
<td align="left" valign="top">171</td>
<td align="left" valign="top">2.70×10<sup>2</sup></td>
</tr>
<tr>
<td align="left" valign="top">R298P</td>
<td align="left" valign="top">6.62×10<sup>2</sup></td>
<td align="left" valign="top">3.66×10<sup>-2</sup></td>
<td align="left" valign="top">2.09×10<sup>-3</sup></td>
<td align="left" valign="top">1.48×10<sup>-3</sup></td>
<td align="left" valign="top">22900</td>
<td align="left" valign="top">2.47×10<sup>3</sup></td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
<p>Interestingly, the ON (K<sub>on</sub>) and OFF (K<sub>off</sub>) rates for a linear substrate RNA differ 2-2.7-fold compared to NEAT2 RNA. A 2.7-fold faster OFF rate on a linear substrate would result in a rapid turnover and higher methylation of the GGACU motif residing in a linear RNA compared to the loop region of a stem-loop RNA. At the same time, the structured elements in RNA can help recruit METTL3-METTL14, as suggested by a 5-fold stronger affinity to NEAT2 RNA. These results suggest the RNA shape surrounding the core ‘GGACU or DRACH’ motif is a crucial determinant of methylation. This observation can explain, in part, why only a fraction of potential DRACH motifs (or perfect GGACU) are methylated <italic>in vivo</italic>.</p>
<p>The SPR data of the two mutant enzymes (R471H and R298P) revealed a change in Rmax and mode of binding. While the SPR data of the WT enzyme fit well with the 1:1 binding model, the mutant data could only fit well with a two-state reaction model (<xref ref-type="table" rid="tbl3">Table 3</xref>). The R298P mutation in METTL14 results in a moderate loss (1.4-1.6-fold) of binding to the stem-loop NEAT2* RNA (Kd=256 vs. 356 nM) and its methylated counterpart (Kd= 337 vs. 538 nM) or the linear r6T RNA (Kd=1360 vs. 2160 nM) but a significant loss (&gt;7-fold) in RNA binding occurred for methylated linear r6T RNA (Kd=3120 vs 22900). On the other hand, the R471H mutant exhibits much slower dissociation after binding, thus hampering the enzyme’s turnover. These data suggest that the two arginines (R471H of METTL3 and R298P of METTL14) in the m6A pocket, which is cryptic in nature, are important for recognizing the methylation status, and the replacement of R298 to proline and R471 to histidine would negatively impact the methylation of the canonical GGACU motif. Of note, striking differences in the mode of binding – two-state binding for R471H/ R298P mutants vs. one-state binding of the WT enzyme – and their dynamics (ON and OFF rates) likely alter the retention time of the enzyme on RNA with varied shapes and sequences or residence time for m6A of these RNAs in the cryptic pocket. Consequently, multi-stage RNA binding and altered dynamics could alter specificity. An independent study by Zhang et al. reported that R298P mutation alters the enzyme’s preference from GG<underline>AC</underline> to GG<underline>AU</underline><sup><xref ref-type="bibr" rid="ref35">35</xref></sup>. In this context, our structural and binding data provides crucial and timely insights into the existence of a cryptic pocket, the importance of two arginines for methylation of the canonical GGACU motifs, and how mutations at these positions could alter the dynamics of RNA binding of METTL3-METTL14 and ultimately alter enzyme specificity.</p>
<p>To assess the dynamic impact of the mutations in METTL3-METTL14 on m<sup>6</sup>A binding, we conducted supervised molecular dynamics simulations (SuMD) and analyzed the distances between the center of mass (com) of the m<sup>6</sup>A and the product m<sup>6</sup>A binding pocket (defined by residues within 4 Å of m<sup>6</sup>A (see methods) over time for wild-type and each mutant, including T433A, K459A, R471H, Δ472-473, Δ472-474, H478A, E481A, and R298P. The wild-type METTL3-METTL14 complex displayed distances around 1.5 Å for most of the simulation time, highlighting the presence of m6A within the product m6A binding pocket (<xref ref-type="fig" rid="fig7">Extended data Fig. 3a</xref> and <xref ref-type="fig" rid="fig8">4a</xref>). Furthermore, this also indicates that the product m<sup>6</sup>A binding pocket in the wild-type is well-structured to accommodate m<sup>6</sup>A securely and thereby maintain a stable binding environment (<xref ref-type="fig" rid="fig7">Extended data Fig. 3b</xref>). In the wild-type, interactions between H478, T472, and m<sup>6</sup>A are observed. Some additional interactions are also formed; for example, T433 and E481 form stable interactions with the phosphate group via a water molecule. A salt bridge between K459 and E481 helps to stabilize the water molecule (<xref ref-type="fig" rid="fig8">Extended data Fig. 4a</xref>). In H478A, which is no longer able to interact with m<sup>6</sup>A, the phosphate group becomes mobile and is unable to anchor to A478 (<xref ref-type="fig" rid="fig8">Extended data Fig. 4f</xref>). In T433A and R298P mutations, the distance between the center of mass of m<sup>6</sup>A and the product m<sup>6</sup>A binding pocket mostly ranged from 2 to 4 Å, suggesting that these mutations, while impactful, do not entirely abolish m<sup>6</sup>A binding (<xref ref-type="fig" rid="fig8">Extended data Fig. 4b, c</xref>). Consequently, these mutants could retain m<sup>6</sup>A in the product m<sup>6</sup>A binding pocket for most of the simulation time. It is interesting to note that in the T433A mutation, in spite of the h-bond interaction between the phosphate group and the side chain of T433 is lost, the interaction between H478 and the phosphate group remains intact (<xref ref-type="fig" rid="fig8">Extended data Fig. 4c</xref>). Therefore, this T433A mutation does not significantly affect the binding of m<sup>6</sup>A. In the case of R298P (<xref ref-type="fig" rid="fig8">Extended data Fig. 4b</xref>), although the <italic>arginine clasp</italic> was broken, the phosphate group remains stabilized in the same position, making interactions with H478. Moreover, E481 in the R289P mutant can also contribute to stabilizing the phosphate group via a water molecule (<xref ref-type="fig" rid="fig8">Extended data Fig. 4b</xref>). However, in the E481A mutant, this water bridge is lost. Similarly, the mutation in K459A results in the loss of a salt bridge with E481, leading to localized destabilization (<xref ref-type="fig" rid="fig8">Extended data Fig. 4d, g</xref>). The resulting electrostatic repulsion between the negatively charged side chains of E481 and the phosphate group of m<sup>6</sup>A pushes the m<sup>6</sup>A out of the product m<sup>6</sup>A binding pocket (<xref ref-type="fig" rid="fig8">Extended data Fig. 4g</xref>). For the two deletion mutants (Δ472-473, Δ472-474), m<sup>6</sup>A immediately leaves the product m<sup>6</sup>A binding pocket after the removal of the constraint in the equilibration steps, highlighting the essential nature of these residues in maintaining the binding pocket’s structure (<xref ref-type="fig" rid="fig8">Extended data Fig. 4h, i</xref>).</p>
</sec>
<sec id="s2-3">
<title>Base swiveling facilitates m<sup>6</sup>A sensing</title>
<p>The two loops in METTL3 (gate loops 1 and 2) surrounding the methyl donor SAM and acceptor base A pockets show varying degrees of flexibility upon SAM and SAH binding from their original positions in a ligand-free (apo) form<sup><xref ref-type="bibr" rid="ref14">14</xref>–<xref ref-type="bibr" rid="ref16">16</xref></sup>. Thus, we compared the m<sup>6</sup>A structure with three states (SAM, SAH, and apo). These loops also move in opposite directions upon m<sup>6</sup>A binding from their original positions in the SAM-bound METTL3 (<xref ref-type="fig" rid="fig3">Fig. 3a</xref>). Gate loop 1 (aa 398-409) moves ~ 5.7Å inward to the direction of m<sup>6</sup>A, whereas the gate loop 2 (aa 506-512) moves ~ 7.8Å outward, with several residues in this region, including H512, that flips ~180º. The invariant T433 and G434 from a small loop between β3 and α2 move ~ 2.1Å with the side chain of T433 rotating ~90º to stabilize the phosphate and ribose of m<sup>6</sup>A (<xref ref-type="fig" rid="fig3">Fig. 3a</xref>). This region remains unperturbed in SAH-bound METTL3, suggesting the m<sup>6</sup>A binding to this pocket occurs after hydrolysis of SAM (<xref ref-type="fig" rid="fig3">Fig. 3b</xref>). While the gate loop 2 in SAH remains in open confirmation, akin to SAM conformation, the position of gate loop 1 in m<sup>6</sup>A experiences significant repositioning of the M402 side chain (<xref ref-type="fig" rid="fig3">Fig 3c</xref>). Although m<sup>6</sup>A-bound METTL3 is most similar to the apo form with the smallest root mean square deviation for superposition of 1539 atoms of METTL3 achieved for apo (1.2), compared to SAH (1.5), and SAM (1.9), we observed notable changes in the m<sup>6</sup>A pocket (<xref ref-type="fig" rid="fig3">Fig. 3c</xref>).</p>
<fig id="fig3" position="float" fig-type="figure">
<label>Figure 3</label>
<caption><title>Base swiveling and loop orchestration.</title>
<p><bold>a-c,</bold> Upper panels show overlays of regions of METTL3 encompassing the catalytic motif, gate loops 1 and 2, and interface loop in METTL3 bound to m<sup>6</sup>A (red stick), SAM (pink stick), and SAH (orange stick). Arrows indicate the directional movement of loops. Lower panels: The entire region of each overlay is in stick mode. Green dots, the residues that form the m<sup>6</sup>A interaction network. <bold>d,</bold> Close-up of an overlay of m<sup>6</sup>A and apo MTase of METTL3-METTL14 shown in two orientations for clarity. The exit channel between M402 and H474 in the m<sup>6</sup>A bound conformation becomes wider (up to 8Å) to stabilize m<sup>6</sup>A and avoid steric clashes with its purine and ribose moieties. <bold>e,</bold> An overlay of MTase cores of arabidopsis METTL4 (light blue cartoons)/SAH (light blue stick)/Am (blue stick) and METTL3 (cyan)-METTL14 (orange)/m<sup>6</sup>A (red stick) clarifies the ~ 120º pivot of the base around phosphate. Black dots, water molecules in the m<sup>6</sup>A structure help stabilize the m<sup>6</sup>A and compensate for the loss in binding energy in the site emptied by base pivoting. <bold>f,</bold> Change in emission fluorescence intensity upon titration of increasing concentration of WT (upper panel) and R298P mutant enzymes (lower panel) with 2-aminopurine (2-Ap) containing RNA (n=3). See the methods section and source data for details.</p></caption>
<graphic xlink:href="3150186v2_fig3.tif" mime-subtype="tif" mimetype="image"/>
</fig>
<p>The side chain of M402 from gate loop 1 in the m<sup>6</sup>A structure stacks over the purine ring of m<sup>6</sup>A. In the SAM-bound form, this region is moved &gt;5Å away, but in the SAH and apo forms, the M402 side chain will sterically clash with m<sup>6</sup>A ribose (distance between Cε of M402 and C4’ of ribose ~1.2 Å). To avoid this clash, the side chain of M402 in m<sup>6</sup>A-METTL3 rotates &gt; 45º, resulting in a ~3.8Å gain in the distance for the Cε atom compared to its position in the apo structure. As a result of this repositioning, the inter-gate area between interface loop (H474) and gate loop 1 (M402) becomes wider, from 6.8Å in apo to 8.0 Å in the m<sup>6</sup>A structure (<xref ref-type="fig" rid="fig3">Fig. 3d</xref>). Thus, gate loop 1 from one side senses the SAM and targets the RNA base at the point of catalysis (<sup>395</sup>DPPW<sup>398</sup> motif). It then swivels after SAM hydrolysis to facilitate the sensing of m<sup>6</sup>A status of the target base at the opposite or <italic>exit</italic> site.</p>
<p>Another change occurs in how the side chain of invariant R298 (METTL14) orients within the <italic>arginine clasp</italic>. The R298 side chain rotates ~180º around its C<sub>β</sub>, although the guanidino group shifts slightly to form a direct h-bond with <italic>N<sup>1</sup></italic> of m<sup>6</sup>A (<xref ref-type="fig" rid="fig3">Fig. 3d</xref>, <xref ref-type="fig" rid="fig5">Extended data Fig. 1g</xref>). The orientation of the gate loops suggests that m<sup>6</sup>A-METTL3 represents a state of enzyme post-catalysis before release of any product or enzyme reset.</p>
<p>How does m<sup>6</sup>A swivel ~16Å from the point of catalysis to occupy this novel pocket in METTL3? To answer this question regarding the mechanism of base-swiveling, we once again employed supervised molecular dynamics (SuMD) simulations. The simulations successfully captured the transition of the m<sup>6</sup>A from the substrate A pocket to the product m<sup>6</sup>A binding pocket. The phosphate group of m<sup>6</sup>A makes h-bond interactions with H478 (<xref ref-type="fig" rid="fig8">Extended data Fig. 4a</xref>). This interaction acts like a hinge and anchors m<sup>6</sup>A, which then allows the nucleotide base in m<sup>6</sup>A to swivel and eventually occupy the product m<sup>6</sup>A binding pocket. Once in the product m<sup>6</sup>A binding pocket, the nucleotide base of m<sup>6</sup>A can form h-bond with R298 (<xref ref-type="fig" rid="fig8">Extended data Fig. 4a</xref>). The most stable structure of the m<sup>6</sup>A in the product m<sup>6</sup>A binding pocket displays a root-mean-square deviation (RMSD) of ~ 2 Å with the resolved crystal structure (<xref ref-type="fig" rid="fig9">Extended data Fig. 5</xref>). This close structural alignment with the crystallographic data highlights the significance of the observed transition mechanism and corroborates with the H478A mutation where the RNA methyltransferase activity is completely abolished in the METTL3-METTL14 complex. To further validate these interactions, we calculated the interaction energy between m<sup>6</sup>A and the METTL3-METTL14 complex (<xref ref-type="fig" rid="fig9">Extended data Fig. 5</xref>-<xref ref-type="fig" rid="fig11">7</xref>). The results showed significant binding affinity and stability, supporting the observed h-bond interactions and the overall structural integrity of m<sup>6</sup>A within the m<sup>6</sup>A binding pocket (<xref ref-type="fig" rid="fig11">Extended data Fig. 7</xref>).</p>
<p>To verify our findings, we superposed m<sup>6</sup>A-METTL3 over the structure of Arabidopsis METTL4, a member of the subclade of the MTA-70 family that possesses the substrate 2’-<italic>O</italic> methyladenosine (A<sub>m</sub>)<sup><xref ref-type="bibr" rid="ref36">36</xref></sup>. The central β-sheet and the catalytic motif of the two enzymes (DPPW) overlay very closely. In this model, the acceptor <italic>N<sup>6</sup></italic> atom of Am resides at ~3Å or less from the methylsulfonium group of SAM for S<sub>N</sub>2 mechanism of direct methyl transfer. The phosphates of A<sub>m</sub> and m<sup>6</sup>A lie in close proximity (~1.2Å). However, their purine and ribose rings are rotated ~120º in opposite directions, suggesting the base (A) pivots after conversion into m<sup>6</sup>A (<xref ref-type="fig" rid="fig3">Fig. 3e</xref>). Such a rotation may necessitate the de-stacking of the target base for its presentation to catalytic pocket and or base swiveling.</p>
<p>A water molecule at the putative site of the substrate A base is present in the m<sup>6</sup>A structure to compensate for the loss in binding energy in the emptied site by rotation of m<sup>6</sup>A from this site post-catalysis. This water coordinates with K459, and its mutation to alanine abolishes the methylation activity (<xref ref-type="fig" rid="fig1">Fig. 1c</xref>). SAM-dependent DNA methyltransferases, including the ancestral members of MTA-70 family MTases such as EcoP15I, efficiently flip the target adenine base out of the DNA helix into the catalytic pocket<sup><xref ref-type="bibr" rid="ref37">37</xref></sup>. Although METTL3-METTL14 does not methylate dsDNA and dsRNA<sup><xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref12">12</xref></sup>, it can still de-stack the target base from a single-stranded RNA into the catalytic pocket, similar to the m<sup>6</sup>A/m<sup>6</sup>A<sub>m</sub> eraser enzyme, FTO<sup><xref ref-type="bibr" rid="ref38">38</xref>,<xref ref-type="bibr" rid="ref39">39</xref></sup>, and the m<sup>6</sup>A reader, YTHDC1<sup><xref ref-type="bibr" rid="ref40">40</xref></sup>. To test this activity, we replaced the target A (6-aminopurine) in a GGAC<underline>U</underline> in a 14-mer ssRNA with 2-aminopurine (2Ap), a fluorescent nucleobase used as a conformational probe due to its high sensitivity to changes in the local environment induced by DNA<sup><xref ref-type="bibr" rid="ref41">41</xref></sup> and RNA MTases<sup><xref ref-type="bibr" rid="ref42">42</xref></sup>. As shown in <xref ref-type="fig" rid="fig3">Fig. 3f</xref>, the change in fluorescence intensity (at 371nm) with increasing enzyme concentrations was rapid for WT but not the R298P mutant enzyme, confirming the diminished RNA binding and base de-stacking ability of the mutant enzyme. While the cellular impact of R298P mutation has been studied in the context of cancer<sup><xref ref-type="bibr" rid="ref33">33</xref></sup>, our data now uncover a precise mechanistic role of R298 in m<sup>6</sup>A sensing. Thus, an elegant orchestration of loops surrounding the SAM/SAH, substrate A, and product m<sup>6</sup>A binding pockets enables m<sup>6</sup>A base swiveling and sensing (see <xref ref-type="supplementary-material" rid="data2">Movie 1</xref>).</p>
<p>To capture an AMP-bound METTL3-14, which could serve as a control structure, we extensively attempted co-crystallization and soaking of AMP into apo crystals but could not observe AMP around the catalytic pocket (DPPW or motif IV) or the m6A binding pocket. We reason the highly mobile nature of the substrate adenine base in the catalytic pocket for this. To gain insights into this phenomenon, we examined the Am binding of the published structure of Arabidopsis METTL4 (PDB: 7CV6)<sup><xref ref-type="bibr" rid="ref36">36</xref></sup>. The slightly low occupancy coupled with high average B-factors (B = 177 Å<sup>2</sup>) of Am base in Arabidopsis METTL4 suggest a highly mobile nature of the Am base in the catalytic pocket (<xref ref-type="fig" rid="fig6">Extended data Fig. 2a</xref>). Furthermore, Am’s RSCC (real space correlation coefficient) score in Arabidopsis METTL4 is 0.66. A value of RSCC score below 0.8 indicates a modest fit<sup><xref ref-type="bibr" rid="ref43">43</xref></sup>. In contrast, the m6AMP in our hMETTL3-METTL14 methyltransferase core structure fits nicely into the electron density at full occupancy (1.0) (<xref ref-type="fig" rid="fig5">Extended data Fig. 1 d-f</xref>). Consistently, an RSCC score of 0.85 with low average B-factors (B = 70 Å<sup>2</sup>) confirms a relatively stable mode of m6A binding to hMETTL3-METTL14 (<xref ref-type="table" rid="tbl4">Extended data Table 1</xref> and PDB validation report).</p>
<p>While our work was in preparation, Corbeski et al. reported crystal structures of METTL3-METTL14 MTase core in complex with synthetic bisubstrate analogs (BAs), wherein methyl donor SAM was covalently linked to the substrate adenosine. These analogs may represent a transition state during methyl transfer<sup><xref ref-type="bibr" rid="ref44">44</xref></sup>. This study suggests that the substrate nucleotide-bound structures of METTL3-METTL14 could only be resolved when the <italic>N<sup>6</sup></italic> of adenosine was covalently attached to SAM via a 2-3 carbon linker. Interestingly, despite spatial restriction imposed by covalent linkage, the substrate adenosine moiety still exhibits significant flexibility within and across crystals obtained from soaking two different analogs, e.g., BA2 and BA4 (<xref ref-type="fig" rid="fig6">Extended data Fig. 2b, c</xref>). For example, the adenosine moiety of the covalent analog BA2 samples two different orientations; in a ‘buried’ conformation, it occupies the substrate pocket of METTL3 and interacts with E481 and K513, whereas in an ‘alternate conformation,’ it rotates ~90º and exposes to the solvent. In the BA4-METTL3-14 structure, the covalently attached substrate adenosine rotates into solvent-exposed orientation while the cosubstrate SAM remains rigid and occupies the SAM-binding pocket in both structures (<xref ref-type="fig" rid="fig6">Extended data Fig. 2b, c</xref>). Importantly, the movement of the adenosine in BA-analogs will be limited due to the covalent linkage to SAM, which naturally has a high affinity. However, the adenosine continuously tries to move in and out of the catalytic pocket. We believe these structures could serve as a control where adenosine is captured in the methyl acceptor state of the <italic>N<sup>6</sup></italic>, precisely the way we modeled it by comparing the METTL4-Am structure. Moreover, the gate loop 1 and the interface loop are disordered in METTL3-14 bisubstrate analog structures, most likely due to the lack of stabilizing interactions. In contrast, these regions of METTL3-14 are well resolved in our m6AMP-bound structure due to their stabilizing interaction with m6AMP. Altogether, these observations suggest a highly mobile nature of the substrate adenine (A) base in the catalytic pocket.</p>
<p>The center of mass distance measurements in the simulations revealed that m<sup>6</sup>A consistently maintained the shortest average distance of ~1.5 Å with low variability, indicating a strong and persistent binding interaction. In contrast, other nucleotides exhibited greater and more variable distances, typically exceeding 2 Å and occasionally reaching up to 5 Å, especially AMP, CMP, and GMP, suggesting weaker and less stable interactions. AMP, CMP, and GMP showed the largest RMSD values, &gt; 4 Å, indicating the least stability in their binding positions (<xref ref-type="fig" rid="fig7">Extended data Fig. 3b</xref>). This instability can be attributed to the inability of M402 to form hydrophobic interactions with the methyl group of m6A. In AMP, the loss of the methyl group prevents M402 from stabilizing the nucleotide. Although AMP can still form strong interactions with the complex, the RMSD plot indicates significant flexibility within the binding pocket. The results from SuMD are in excellent agreement with our experimental findings, which highlight the specific binding preference of the METTL3-METTL14-core for m<sup>6</sup>A.</p>
</sec>
<sec id="s2-4">
<title>METTL3-METTL14 acts as an atypical m<sup>6</sup>A sensor</title>
<p>The m<sup>6</sup>A-METTL3-METTL14 structure allowed us to gain valuable insights into how m<sup>6</sup>A writer (METTL3-METTL14), eraser (FTO), and reader (YTHDC1) proteins accommodate m<sup>6</sup>A. We examined their m<sup>6</sup>A pocket in detail (<xref ref-type="fig" rid="fig4">Fig. 4a-c</xref>). Despite the lack of obvious resemblance at the protein sequence, domain, and structure levels, we observed high similarity in the interaction networks of m<sup>6</sup>A in METTL3-METTL14 to the binding mode of 6mA in FTO (PDB: 5ZMD) and m<sup>6</sup>A in YTHDC1 (PDB: 4R3I) (<xref ref-type="fig" rid="fig4">Fig. 4</xref>). Of note, the purine ring of 6mA in FTO stacks between a hydrophobic amino acid, L109 (the equivalent of M402 in m<sup>6</sup>A), from the top and the backbone atoms of V228, S229, and H231 (the equivalent of T472, G473, and H474 in m<sup>6</sup>A) from the bottom. Interestingly, the <italic>arginine clasp</italic> we found in m<sup>6</sup>A-METTL3-METTL14 is also present in 6mA-FTO. Notably, the side chain of R96 in FTO forms a direct h-bond to <italic>N<sup>1</sup></italic> of 6mA, while the guanidino group of its R322 residue forms a van der Waals interaction with <italic>N<sup>6</sup></italic> methyl group, akin to identical interactions by R298 and R471 to stabilize m<sup>6</sup>A in m<sup>6</sup>A-METTL3-METTL14. Stacking interactions that lock the sugar moieties in place also display similarities. For example, the sugar of 6mA in FTO stacks between I85 and H231, whereas the sugar of m<sup>6</sup>A stacks between I400 and H478 of METTL3 (<xref ref-type="fig" rid="fig4">Fig. 4a, b</xref>).</p>
<fig id="fig4" position="float" fig-type="figure">
<label>Figure 4</label>
<caption><title>Mode of m<sup>6</sup>A binding by writer/sensor, eraser, and reader.</title>
<p>Interaction networks of m<sup>6</sup>A (red) binding to METTL3 (green), and METTL14 (<bold>a</bold>), 6mA (blue) binding to FTO (<bold>b</bold>), and m6A binding to YTH domain of YTHDC1 (<bold>c</bold>). The two nucleotides flanking the flipped methylated base in FTO and YTHDC1 are shown in light blue and grey, respectively. The hydrophobic stacking surface in YTHDC1 can only be aligned by rotating the molecule 180º around the x-axis, suggesting that reader proteins approach RNA from the opposite direction. The m<sup>6</sup>A pocket of METTL3-METTL14 harbors features that enable it to act as an atypical m<sup>6</sup>A sensor/reader during its switch from writer to reader. Dashed lines, h-bonds.</p></caption>
<graphic xlink:href="3150186v2_fig4.tif" mime-subtype="tif" mimetype="image"/>
</fig>
<p>We found that m<sup>6</sup>A in METTL3-14 and YTHDC1 (PDB: 4R3I) had many similarities and striking differences, mainly in the orientation of the base (<xref ref-type="fig" rid="fig4">Fig. 4c</xref>). The <italic>N<sup>1</sup></italic> of m<sup>6</sup>A forms an h-bond with N367, whereas an h-bond with carbonyl of S378 akin to carbonyl of R471 of METTL3 stabilizes the <italic>N<sup>6</sup></italic>. Additional hydrophobic interactions from W377 and W428 also support the <italic>N<sup>6</sup></italic> methyl group in YTHDC1. The nature of stacking interactions for the purine ring is also similar, i.e., hydrophobic residues M434, L380, and L439 on one side and backbone atoms of K361, S362, and N363 on the other. However, the orientation of the m<sup>6</sup>A base in YTHDC1 is reversed by 180º compared to 6mA in FTO and m<sup>6</sup>A in METTL3-14. As such, when the direction of sugars and phosphates of modified bases is aligned in three structures (facing downward in <xref ref-type="fig" rid="fig4">Fig. 4a, b</xref>, and upper panel of <xref ref-type="fig" rid="fig4">c</xref>), the hydrophobic residues (M434/L380/L439) in YTHDC1 stack from the bottom side and the backbone atoms of K361, S362, and N363 stack from the top side, in contrast to the base orientation in FTO and METTL3. A ~180º rotation of YTHDC1 will place the interacting residues in all three proteins in the same plane. However, the orientation of ribose and phosphate of m<sup>6</sup>A in YTHDC1 will also be reversed (facing upward, <xref ref-type="fig" rid="fig4">Fig. 4c</xref> lower panel). Thus, a m<sup>6</sup>A reader protein approaches the m<sup>6</sup>A entirely differently than a writer or eraser. This unique geometric difference may allow the reader to avoid clashes with a writer or eraser enzyme acting simultaneously on the same transcript.</p>
<p>There could be two scenarios for stabilizing m6A in the cryptic pocket: <bold>a.</bold> The pocket may have the capacity to bind to all nucleotides, but m6A can outcompete other nucleotides due to its higher binding affinity to the MTase core. <bold>b</bold>. The pocket may exclusively interact with m6A while nucleotides flanking A/m6A weakly interact with other RNA binding domains of METTL3-14. Consequently, mutations near the pocket could disrupt the binding to m6A or alter the preference from m6A to other nucleotides. We show that METTL3 possesses features that enable it to act as an atypical m<sup>6</sup>A sensor/reader – a function ideally suited for its emerging non-catalytic functions, including crosstalk with eIF3H to promote mRNA circularization, thereby enhancing RNA translation as observed in lung cancer<sup><xref ref-type="bibr" rid="ref23">23</xref>,<xref ref-type="bibr" rid="ref25">25</xref></sup> and bone marrow mesenchymal stem cells<sup><xref ref-type="bibr" rid="ref21">21</xref></sup>. Consistently, METTL3 exhibits a strong affinity to a methylated (m<sup>6</sup>A) RNA form, especially those containing secondary structures, a feature that could be important for its non-catalytic roles such as an ‘m<sup>6</sup>A reader’ for an alternative mode of translation initiation during oncogenic translation<sup><xref ref-type="bibr" rid="ref23">23</xref>,<xref ref-type="bibr" rid="ref25">25</xref></sup> and cellular stress (e.g., heat shock)<sup><xref ref-type="bibr" rid="ref34">34</xref></sup>.</p>
</sec>
</sec>
<sec id="s3" sec-type="methods">
<title>Methods</title>
<sec id="s3-1">
<title>METTL3-METTL14 MTase core</title>
<p>The gene encoding the MTase domains of human METTL3 (aa 357-580aa) and METTL14 (aa 116-402) were cloned into a pETduet-1 vector and expressed in E. coli NiCo21(DE3) cells. The transformed cells were grown in Terrific Broth medium supplemented with 1 mM ampicillin at 37°C until OD<sub>600nm</sub> reached 0.6. Protein expression was then induced by adding 0.4 mM isopropyl β-D-thiogalactopyranoside, and the culture was grown at 18°C for 16 hrs. The cell pellets were harvested by centrifugation at 6000 r.p.m. at 4°C and resuspended in cold lysis buffer containing 25 mM Tris pH 8.0, 0.5 M NaCl, 10% glycerol, 5 mM imidazole, 0.1 mM TCEP, one tablet of protease inhibitor (Roche), lysozyme (0.1 mg/mL), and DNase I (5U/mL) and stirred gently at 4°C until achieving full homogeneity. Resuspended cells were lysed by two passages through a microfluidizer (Analytik, UK) and subjected to centrifugation at 41,000 r.p.m. for 50 min at 4°C. The clarified supernatant was filtered through a 0.22 μm filter and loaded onto a Nuvia IMAC column (Bio-Rad) pre-equilibrated with wash buffer (25 mM Tris pH 8.0, 0.5mM NaCl, 10% glycerol, 5 mM imidazole, and 0.1 mM TCEP). The His-tagged METTL3 was co-eluted with untagged METTL14 by increasing the imidazole concentration. The eluates were dialyzed in a buffer lacking imidazole overnight at 4ºC in the presence of the ULP1 enzyme to remove the His-SUMO tag from METTL3 proteolytically. The dialyzed proteins were then re-loaded onto an IMAC column to remove un-cleaved proteins and the His-SUMO tag. Two successive passages through MonoQ and Hiload Superdex75 columns (Cytiva) further purified the tag-free complex. The fractions of a homogenous peak eluted in 20 mM Tris pH 8.0, 0.2 M NaCl, and 0.1mM TCEP were pooled, concentrated to 15 mg/ml, and either used immediately or flash-frozen in liquid nitrogen and then stored at -80°C.</p>
</sec>
<sec id="s3-2">
<title>Full-length METTL3-METTL14 and mutants</title>
<p>The full-length human METTL3 and METTL14 (wild-type and mutants) were expressed in insect cells (ExpiSF Expression System, Thermo Fisher) and purified using a protocol published earlier<sup><xref ref-type="bibr" rid="ref12">12</xref></sup>. In brief, the METTL3 and METTL14 plasmids were transformed individually into Max Efficiency DH10Bac competent cells (Thermo Fisher) to generate the DNA bacmids. The successful insertion of genes was confirmed by PCR amplification using a pUC/M13 primer (Forward: 5’-CCCAGTCACGTTGTAAAACG -3’, Reverse: 5’ – AGCGGATAACAATTTCACACAGG -3’). The amounts of purified bacmids and ExpiFectamine SF transfection reagent (Thermo Fisher) were optimized as per the manufacturer’s recommendations (Thermo Fisher). The ExpiSf9 insect cells were cultured in ExpiCD medium (Thermo Fisher) at 125 r.p.m. and 27°C in a non-humidified, air-regulated environment. The cells were harvested 72 hrs post-infection by spinning at 300 × g for 5 min. The PBS-washed cells were resuspended in cold lysis buffer containing 0.5% Igepal, two tablets of protease inhibitor (Roche), and DNase I. Cells were lysed by passing through a microfluidizer (Analytick, UK) and clarified by centrifugation at 41,000 r.p.m. for 40 min.</p>
<p>The proteins were purified using a strategy similar to that of the MTase core, except for removing the His-tag from METTL3. This step was achieved by incubating proteins after the affinity column step with TEV protease for 3 hrs at room temperature. A second passage through a nickel IMAC column removed contaminants and any uncleaved fractions. The complex was then successfully purified by successive passages through HiTrap Heparin and Hiload Superdex 200 columns (Cytiva). Eluates from a homogenous peak of a Superdex column run in a buffer of 0.02 M Tris pH 8.0, 0.15 M NaCl, and 5% glycerol were pooled, concentrated to 1-3 mg/ml, and flash-frozen in liquid nitrogen and stored at -80°C. All full-length METTL3-METTL14 mutants (METTL3: T433A, K459A, R471H, Δ472-473; Δ472-474, H478A, E481A; METTL14: R298P) were generated by site-directed mutagenesis and purified by the same method as the wild-type protein.</p>
</sec>
<sec id="s3-3">
<title>Crystallization, data collection, and structure determination</title>
<p>The crystallization of the human METTL3-METTL14 MTase core (at 10 mg/mL concentration) was carried out by an OryxNano robotic system (Douglas Instruments) using the sitting-drop vapor diffusion method at 20°C. Initial crystals were grown in a solution containing 0.1 M MES pH 6.0, 1.0 M potassium sodium tartrate. After several rounds of optimization by varying pH and salt concentrations, large reproducible crystals were grown in seven days. The <italic>N<sup>6</sup></italic>-methyladenosine monophosphate (m<sup>6</sup>AMP; Sigma, M2780) was soaked into native crystals (2.0 mM concentration) for 1 hr at 20°C. A complete diffraction dataset was measured to ~2.5Å at GMCAT 23ID-D beamline at Advanced Photon Source, Chicago, IL. The apo structure of METTL3-METTL14 MTase core (PDB: 5IL0) was used as a search model for molecular replacement in Phenix<sup><xref ref-type="bibr" rid="ref45">45</xref></sup>. The structure was iteratively built and refined using Coot (Version 0.9.8.6)<sup><xref ref-type="bibr" rid="ref46">46</xref></sup>, Phenix (Version 1.15.2-3472) and Buster (Version 2.10.4)<sup><xref ref-type="bibr" rid="ref47">47</xref></sup>, respectively. The ligand geometry restraints were generated by Grade. All structure figures were generated using Pymol (Schrodinger Suite).</p>
</sec>
<sec id="s3-4">
<title><italic>In vitro</italic> methyltransferase assays</title>
<p>5 μM [methyl-<sup>3</sup>H] SAM (PerkinElmer), 10 μM substrate RNA (NEAT2*: 5’ – GCCUAGUAGCAGAGA<underline>GGACU</underline>GCUCCUUGGU - 3’), and 2 μM purified WT or mutated METTL3-METTL14 were mixed and incubated at 37°C for 1 hr in a total volume of 5 μL in a reaction buffer (50 mM HEPES pH 7.5, 5 mM NaCl, and 1 mM DTT). The reactions were quenched by blotting 3 μL of each on the Hybond-N+ membrane (Amersham). The methylated substrates were then crosslinked by exposing them to ultraviolet light (254 nm) for 2 min. The membranes were washed three times with 1X PBS, followed by two 95% ethanol washes. Then the membranes were air-dried inside the hood for 15 minutes, and the RNA probe’s count per minute (c.p.m.) on each membrane were measured by a scintillation counter (Beckman LS6500). All results are reported as the means from three independent experiments (n=3) for each group, with one standard deviation (s.d.).</p>
</sec>
<sec id="s3-5">
<title>Fluorescence polarization</title>
<p>The reactions were carried out in a buffer containing 10 mM HEPES pH 7.5 and 50 mM KCl. The two 30-mer RNA probes (native RNA or A-RNA and its m<sup>6</sup>A-modified version or m<sup>6</sup>A-RNA) were synthesized with a fluoresceine moiety covalently attached to their 5’-end, de-protected, and purified using HPLC (HorizonDiscovery). The sequence of A-RNA was identical except the target A base within the characteristic motif (underlined and bold) in native A-RNA (Fl-NEAT2*: 5’ – [Fl]GCCUAGUAGCAGAGA<underline>GG<bold>A</bold>CU</underline>GCUCCUUGGU - 3’), was replaced by <italic>N<sup>6</sup></italic>-methyladenosine (m<sup>6</sup>A) in the modified RNA (Fl-NEAT2*-m<sup>6</sup>A: 5’ – [Fl]GCCUAGUAGCAGAGA<underline>GG<bold>[m<sup>6</sup>A]</bold>CU</underline>GCUCCUUGGU - 3’). A constant 5 nM of RNA probes were incubated with increasing concentrations of the purified WT or mutant METTL3-METTL14 enzymes in a 384-well plate. The fluorescence polarization values (excitation wavelength = 485 nm, emission wavelength = 530 nm) of each reaction were measured by PHERAstar FS (BMG Labtech). The affinity of RNA-protein binding was calculated by a simple one-site specific binding model (Y = Bmax*X/(Kd+X), X = protein concentration, Y = specific binding, Bmax = maximum specific binding, Kd = equilibrium dissociation constant). The results were analyzed and fitted by GraphPad Prism (GraphPad Software, San Diego, CA). Each experiment was repeated three times independently (n=3), and final <italic>K<sub>d</sub></italic> is reported as the mean of the three replicates with standard deviation (s.d.) for each RNA shown as error bars.</p>
</sec>
<sec id="s3-6">
<title>Steady-state fluorescence assays</title>
<p>For this experiment, we used a 14-mer single-stranded RNA probe in which the the target adenine base within the m<sup>6</sup>A motif was replaced with 2-aminopurine (2-Ap) (r6T*: 5’ – CUUC<underline>GG[2-Ap]CU</underline>CUGCU – 3’). In a 384-well plate format, 0.5 μM of RNA probe mixed with increasing concentrations (1 – 5 μM) of full-length human WT or mutant METTL3-METTL14 enzymes in a 20 μL reaction in the buffer containing 50 mM Tris pH 8.0, and 10 mM MgCl<sub>2</sub> and incubated at room temperature. The reaction was excited at 320 nm with a 325 nm cut-off wavelength in a SpectraMax M5 microplate reader (MolecularDevices). The fluorescence emission was measured at 371 nm and 37°C every 5 minutes from 0 - 60 minutes and then every 30 minutes until the end time point (120 minutes). The data were analyzed and fitted by GraphPad Prism (GraphPad Software, San Diego, CA) using the Michaelis-Menten model (Y=Vmax*X/(Km+X), X = protein concentration, Y = enzyme velocity, Vmax = maximum enzyme velocity, Km = Michaelis-Menten constant). All results reported are mean values from three independent experiments with standard deviations (s.d.) shown as error bars.</p>
</sec>
<sec id="s3-7">
<title>Surface plasmon resonance (SPR)</title>
<p>The surface plasmon resonance experiments were performed using a Biacore 1S+ equipped with a CM5 sensor chip. Recombinant streptavidin (Millipore Sigma, 11721674001) was first immobilized at all six flow cells using amine-coupling chemistry. The surfaces of flow cells were activated for 7 min with a 1:1 mixture of 0.1 M NHS (N-hydroxysuccinimide) and 0.4 M EDC (3-(N, N-dimethylamino) propyl-N-ethylcarbodiimide) at a flow rate of 10 μl/min. The streptavidin at a concentration of 50 μg/ml in 10 mM sodium acetate, pH 5.5, was immobilized at a density of around 6,000 RU on all six flow cells. All surfaces were blocked with a 7-minute injection of 1 M ethanolamine, pH 8.0. The biotinyl-RNA substrates were then diluted to 100nM in running buffer (10mM HEPES, 150mM KCl, 0.05% P20, pH 7.5) and captured in flow cell 3-6 respectively (12s, 5 μl/min) to reach a level around 50RU (see details below). To measure kinetic binding data, the analytes (METTL3-METTL14<sub>WT</sub>, METTL3-METTL14<sub>R298P</sub>, and METTL3-METTL14<sub>R471H</sub> proteins) were diluted in the same running buffer, with five concentrations ranging from 2.4 to 1500 nM. The analytes were then injected over all flow cells at various concentrations in single-cycle kinetics format at a flow rate of 30 μl/min at 25°C. The analyte was allowed to associate and dissociate for 120 seconds for each injection and dissociate for 1200 seconds, respectively. Data were collected at a rate of 10 Hz. The data were fit to a 1:1 binding model or two-state reaction model, as mentioned, using the data analysis option available within Biacore Insight Evaluation Software (Version 5.0.18.22102).</p>
</sec>
<sec id="s3-8">
<title>Molecular Dynamics Simulations</title>
<sec id="s3-8-1">
<title>Structure preparation</title>
<p>The crystal structure of the METTL3-METTL14 complex bound to M<sup>6</sup>A was used as the starting point for all classical molecular dynamics simulations. The AlphaFold model of the METTL14 subunit (UniProt identifier: AF-Q3UIK4-F1) was integrated into the original crystal structure, filling in the gaps and creating a refined METTL3-METTL14 enzyme structure that accounted for the missing residues. Mutants T433A, K459A, R471H, H478A, E481A, and R298P were generated using ICM-Pro software (<ext-link ext-link-type="uri" xlink:href="http://www.molsoft.com">www.molsoft.com</ext-link>). Additionally, the Δ472-473 and Δ472-474 deletions were obtained from the AlphaFold model. The refined structure was aligned to the crystal structure (PDB ID: 7CV6), and the position of S-adenosyl-L-homocysteine was identified as the initial position of m<sup>6</sup>A for the m<sup>6</sup>A-bound METTL3-METTL14 complex. The ProteinPrepare module implemented in the PlayMolecule was employed to assign the protonation states of residues at pH 7.0<sup><xref ref-type="bibr" rid="ref48">48</xref></sup>.</p>
</sec>
<sec id="s3-8-2">
<title>System setup and simulation protocol</title>
<p>The simulations were conducted using the Amberff14SB force field for the protein<sup><xref ref-type="bibr" rid="ref49">49</xref></sup>. The m<sup>6</sup>A was subjected to geometry optimization using Gaussian 16 (HF/631G*) (<ext-link ext-link-type="uri" xlink:href="http://www.gaussian.com">www.gaussian.com</ext-link>). The m<sup>6</sup>A parameters were derived with GAFF as implemented in Ambertools23 using antechamber and parmchk tools<sup><xref ref-type="bibr" rid="ref50">50</xref></sup>. RESP partial charges were calculated with Gaussian 16 following the procedure suggested by antechamber<sup><xref ref-type="bibr" rid="ref51">51</xref></sup>. The preprocessed structure was explicitly solvated in a cubic periodic of water molecules represented by the transferrable intermolecular potential with 3 points (TIP3P), whose boundary is at least 10 Å from any solute atoms so that the protein does not interact with its periodic images. Periodic boundary conditions in all directions were utilized to reduce the finite system size effects. To neutralize the total charge, Na<sup>+</sup>/Cl<sup>−</sup> counterions were added. Subsequently, the systems were energy minimized by 5000 steps with the conjugate gradient method to remove any local atomic clashes. Initial velocities within each simulation were sampled from Boltzmann distribution at a temperature of 300 K. The solvents were equilibrated for five ns under the NPT ensemble. The production simulations of supervised molecular dynamics were run under the NVT ensemble using a Langevin thermostat with a damping of 0.1 ps<sup>-1</sup> and hydrogen mass repartitioning scheme to achieve time steps of 2 fs. Berendsen thermostat and Langevin barostat were used to keep the temperature and pressure constant, respectively<sup><xref ref-type="bibr" rid="ref52">52</xref></sup>. Long-range electrostatic interactions were computed using the particle mesh Ewald summation method<sup><xref ref-type="bibr" rid="ref53">53</xref></sup>. The cutoff radius for neighbor searching and nonbonded interactions was taken to be 9 Å with a switching distance of 7.5 Å was used, and all bonds were constrained using the LINCS algorithm<sup><xref ref-type="bibr" rid="ref54">54</xref></sup>. In total, &gt; 20 SuMD simulations were run as a swarm. Of these, the first three replicas that met the supervision criteria were selected for analysis. All simulations were run using the ACEMD engine<sup><xref ref-type="bibr" rid="ref55">55</xref></sup>.</p>
</sec>
<sec id="s3-8-3">
<title>Supervision procedure</title>
<p>Supervised molecular dynamics is a method that can accelerate the binding process between ligands and protein recognition without introducing bias<sup><xref ref-type="bibr" rid="ref56">56</xref></sup>. This method employs an algorithm that monitors the distance between the ligand and the protein. Short simulations of specific lengths are run, and the distance between the ligand and the protein is calculated. The fitting of linear least squares is applied to fit the data, showing the distance against time. If the slope of the resulting straight line is negative, indicating that the ligand is approaching the binding site, then the state of the last frame, including the velocity and the coordinates of this short trajectory, will be used as the initial state for the next short trajectory. On the contrary, if the slope is positive, thereby indicating that the ligand is not approaching the binding site, the short trajectory will be discarded, and the simulation will restart from the last initial state. However, to avoid the ligand being stuck, assessed by 10 consecutive failed steps, a relatively longer simulation is run, followed by the final state of the simulation being used as the starting point for the successive step. The supervision algorithm is switched off when the distance reaches a defined threshold value. To explore the m<sup>6</sup>A swivel from substrate A binding pocket to product m<sup>6</sup>A binding pocket, a supervision protocol was designed in two steps. In the first step, during the production run of the MD trajectory, the distance between the center of mass of the m<sup>6</sup>A and the center of mass of the residues constituting the product m<sup>6</sup>A binding pocket (METTL3: I400, M402, T433, G434, R435, R471, T472, G473, H474, H478, E481, and METTL14: R298) is monitored over a fixed time window (0.02ns). In the second step, the distances between two key atom pairs were calculated, namely R298:NH1-m<sup>6</sup>A:N1 and H478:ND1-m<sup>6</sup>A:P1. The trajectory analysis was carried out, and the figures were made using PyMol (<ext-link ext-link-type="uri" xlink:href="http://www.pymol.org">www.pymol.org</ext-link>) and VMD<sup><xref ref-type="bibr" rid="ref57">57</xref></sup>. The graphs were made using Python scripts.</p>
</sec>
</sec>
</sec>
</body>
<back>
<sec id="s5">
<title>Additional information</title>
<sec id="s5a">
<title>Author contributions</title>
<p>Y.K.G. conceived, designed, and supervised the overall study; S.Q. A.K. purified proteins and performed biochemical assays. M.P., C.V., and N.G. assisted with protein purification. S.Q. performed crystallography. S.Z. performed SPR experiments. S.C. and S.H. performed molecular dynamics. S.H.C., M.K.R., and S.F.M. provided critical reagents. S.Q, A.K., S.C, S.Z., S.H., and Y.K.G. analyzed data. Y.K.G. wrote the manuscript with input from all authors. All authors approved this version.</p>
</sec>
</sec>
<sec id="s7">
<title>Supplementary material</title>
<table-wrap id="tbl4" position="float" orientation="portrait">
<label>Extended data Table 1</label>
<caption><title>Data collection and refinement statistics (molecular replacement)</title></caption>
<alternatives>
<graphic xlink:href="3150186v2_tbl4.tif" mime-subtype="tif" mimetype="image"/>
<table frame="void" rules="rows">
<thead>
<tr>
<th align="left" valign="top"/>
<th align="left" valign="top">METTL3-METTL14-m6A (PDB: 9DGJ)</th>
</tr>
<tr>
<th align="left" valign="top">Data collection</th>
<th align="left" valign="top"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Wavelength (Å)</td>
<td align="left" valign="top">1.033</td>
</tr>
<tr>
<td align="left" valign="top">Space Group</td>
<td align="left" valign="top">P4<sub>1</sub>2<sub>1</sub>2</td>
</tr>
<tr>
<td align="left" valign="top">Cell dimensions</td>
<td align="left" valign="top"/>
</tr>
<tr>
<td align="left" valign="top"> a=b, c (Å)</td>
<td align="left" valign="top">95.98, 121.61</td>
</tr>
<tr>
<td align="left" valign="top"> α=β=γ(<sup>o</sup>)</td>
<td align="left" valign="top">90</td>
</tr>
<tr>
<td align="left" valign="top">Resolution (Å)</td>
<td align="left" valign="top">2.5</td>
</tr>
<tr>
<td align="left" valign="top">R-merge (%)</td>
<td align="left" valign="top">18.8 (156)<xref ref-type="table-fn" rid="tf4-1">*</xref></td>
</tr>
<tr>
<td align="left" valign="top"><italic>I/σI</italic></td>
<td align="left" valign="top">10.6 (1.76)</td>
</tr>
<tr>
<td align="left" valign="top">Completeness (%)</td>
<td align="left" valign="top">100 (100)</td>
</tr>
<tr>
<td align="left" valign="top">Redundancy</td>
<td align="left" valign="top">9.7 (10.3)</td>
</tr>
<tr>
<td align="left" valign="top">CC1/2</td>
<td align="left" valign="top">0.99 (0.50)<xref ref-type="table-fn" rid="tf4-1">*</xref></td>
</tr>
<tr>
<td align="left" valign="top">Wilson B-factor</td>
<td align="left" valign="top">47</td>
</tr>
<tr>
<td align="left" valign="top"><bold>Refinement</bold></td>
<td align="left" valign="top"/>
</tr>
<tr>
<td align="left" valign="top">Resolution (Å)</td>
<td align="left" valign="top">37.34 – 2.5</td>
</tr>
<tr>
<td align="left" valign="top">Number of reflections</td>
<td align="left" valign="top">20306 (2238)</td>
</tr>
<tr>
<td align="left" valign="top"><italic>R<sub>work</sub></italic> (%) / <italic>R<sub>free</sub></italic> (%)</td>
<td align="left" valign="top">23 / 26.2</td>
</tr>
<tr>
<td align="left" valign="top">Nonhydrogen atoms</td>
<td align="left" valign="top"/>
</tr>
<tr>
<td align="left" valign="top"> Protein</td>
<td align="left" valign="top">3986</td>
</tr>
<tr>
<td align="left" valign="top"> Ligands</td>
<td align="left" valign="top">32</td>
</tr>
<tr>
<td align="left" valign="top"> Water</td>
<td align="left" valign="top">90</td>
</tr>
<tr>
<td align="left" valign="top">Average B-factors (Å<sup>2</sup>)</td>
<td align="left" valign="top"/>
</tr>
<tr>
<td align="left" valign="top"> Protein</td>
<td align="left" valign="top">53.2</td>
</tr>
<tr>
<td align="left" valign="top"> Ligands (m<sup>6</sup>AMP)</td>
<td align="left" valign="top">70.9</td>
</tr>
<tr>
<td align="left" valign="top"> Water</td>
<td align="left" valign="top">47.3</td>
</tr>
<tr>
<td align="left" valign="top">Root mean square deviations</td>
<td align="left" valign="top"/>
</tr>
<tr>
<td align="left" valign="top"> Bond lengths (Å)</td>
<td align="left" valign="top">0.016</td>
</tr>
<tr>
<td align="left" valign="top"> Bond angles (<sup>o</sup>)</td>
<td align="left" valign="top">1.4</td>
</tr>
<tr>
<td align="left" valign="top">Ramachandran favored (%)</td>
<td align="left" valign="top">94.6</td>
</tr>
<tr>
<td align="left" valign="top">Ramachandran allowed (%)</td>
<td align="left" valign="top">4</td>
</tr>
<tr>
<td align="left" valign="top">Ramachandran outliers (%)</td>
<td align="left" valign="top">1.4</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="tf4-1"><label>*</label><p>Values for the outermost shell are given in parentheses.</p></fn>
</table-wrap-foot>
</table-wrap>
<fig id="fig5" position="float" fig-type="figure">
<label>Extended data Figure 1</label>
<caption><p><bold>a,</bold> Coomassie-stained SDS-PAGE showing high purity of METTL3-METTL14 MTase core. <bold>b,</bold> Size-exclusion chromatography coupled with multi-angle scattering estimated a molecular mass of this complex of ~59 kDa, in excellent agreement with theoretical mass (~ 60 kDa). <bold>c,</bold> crystals of METTL3-METTL14 MTase core used for soaking <italic>N<sup>6</sup></italic>-methyladenosine monophosphate (m<sup>6</sup>AMP or m<sup>6</sup>A). <bold>d,</bold> A green mesh showing an unbiased electron density omit map countered at 2.2σ, confirming the presence of m<sup>6</sup>A. <bold>e-f,</bold> A blue mesh representing a 2Fo-Fc map (σ = 1.0) showing the final refinement of the m<sup>6</sup>A-METTL3-METTL14 structure. The map confirms the excellent agreement between calculated and observed electron density for the region surrounding m<sup>6</sup>A and for m<sup>6</sup>A itself (<bold>f</bold>). <bold>g,</bold> Network of interaction between m<sup>6</sup>A and residues from METTL3 (green) and METTL14 (orange). <bold>g,</bold> Quantitative measurement of 30-mer RNA (left panel, A-RNA; right panel, m<sup>6</sup>A-RNA) binding (n = 3) to the WT and mutant enzymes shown as binding isotherms fitted with a one-site specific binding model, (Y=Bmax*X/(<italic>K<sub>d</sub></italic> + X). The equilibrium dissociation constant (<italic>K<sub>d</sub></italic>) was derived from three independent experiments, with error bars indicating the range of data points (n = 3). m<sup>6</sup>A replaces the central adenine base within the GG<underline>A</underline>CU motif in A-RNA in m<sup>6</sup>A-RNA. See the methods section and source data for details.</p></caption>
<graphic xlink:href="3150186v2_fig5.tif" mime-subtype="tif" mimetype="image"/>
</fig>
<fig id="fig6" position="float" fig-type="figure">
<label>Extended data Figure 2</label>
<caption><p><bold>a,</bold> Am (blue stick) binding into ‘DPPW (or motif IV)’ in Arabidopsis METTL4 (green stick, PDB: 7CV6). Blue mesh, 2Fo-Fc electron density map contoured at σ = 0.97. <bold>b,</bold> BA2 SAM-Adenosine covalent analog sampling two different conformations in human METTL3-14 MTase in complex with BA2 (Corbeski et al., PMID: 38470714). <bold>c.</bold> Overlay of METTL3-14 MTase core bound to BA2 and BA4 analogs and m6A (this study)<bold>.</bold></p></caption>
<graphic xlink:href="3150186v2_fig6.tif" mime-subtype="tif" mimetype="image"/>
</fig>
<fig id="fig7" position="float" fig-type="figure">
<label>Extended data Figure 3</label>
<caption><title>The distance between the center of mass of m<sup>6</sup>A and the center of mass of the product m<sup>6</sup>A binding pocket for (<bold>a</bold>) mutants and (<bold>b</bold>) nucleotides.</title></caption>
<graphic xlink:href="3150186v2_fig7.tif" mime-subtype="tif" mimetype="image"/>
</fig>
<fig id="fig8" position="float" fig-type="figure">
<label>Extended data Figure 4</label>
<caption><title>The most stable conformation of the mutants, as identified from SuMD simulations.</title></caption>
<graphic xlink:href="3150186v2_fig8.tif" mime-subtype="tif" mimetype="image"/>
</fig>
<fig id="fig9" position="float" fig-type="figure">
<label>Extended data Figure 5</label>
<caption><title>The distance between the center of mass of (<bold>a</bold>) m6A and the center of mass of the product m<sup>6</sup>A binding pocket; the distance between m<sup>6</sup>A and (<bold>b</bold>) H478 and (<bold>c)</bold> R298 and (<bold>d</bold>) the plots of interaction energies from the three replicas of SuMD.</title></caption>
<graphic xlink:href="3150186v2_fig9.tif" mime-subtype="tif" mimetype="image"/>
</fig>
<fig id="fig10" position="float" fig-type="figure">
<label>Extended data Figure 6</label>
    <caption><title>The base swiveling mechanism of m<sup>6</sup>A between the starting conformation (orange) and the end (green) conformation.</title>
    <p>Different snapshots of m<sup>6</sup>A are illustrated in cpk sticks. The arrow shows the direction of the swiveling nucleotide.</p></caption>
<graphic xlink:href="3150186v2_fig10.tif" mime-subtype="tif" mimetype="image"/>
</fig>
<fig id="fig11" position="float" fig-type="figure">
<label>Extended data Figure 7</label>
<caption><title>The interaction energy between m<sup>6</sup>A and the product m<sup>6</sup>A binding pocket of the wild-type and mutants.</title></caption>
<graphic xlink:href="3150186v2_fig11.tif" mime-subtype="tif" mimetype="image"/>
</fig>
<sec id="s9" sec-type="supplementary-material">
<title>Additional file</title>
<supplementary-material id="data2">
<label>Movie 1.</label>
<caption><title>Loop dynamics during conversion of A to m<sup>6</sup>A and sensing by METTL3-METTL14</title>
<p>An animation shows the motions in two gate loops and the interface loop of METTL3-METTL14. The model for catalysis and m<sup>6</sup>A sensing was generated by ChimeraX (UCSF). The position of A during methylation is modeled by overlaying METTL3-SAM (PDB: 5IL1) with METTL4-Am (PDB: 7CV6). The coordinates used for generating the morph movie are as follows: METTL3-METTL14: m<sup>6</sup>A (this study) apo (PDB: 5IL0), SAM (PDB: 5IL1), SAH (PDB: 5IL2).</p></caption>
<media id="SD2" content-type="supplement" mimetype="application" mime-subtype="mov" xlink:href="3150186v2-data2.mov"/>
</supplementary-material>
</sec>
</sec>
<sec id="s4" sec-type="data-availability">
<title>Data availability</title>
<p>The coding sequences of METTL3 (NCBI reference sequence GI: 33301371) and METTL14 (NCBI reference sequence GI: 172045930) used in this study are available at NCBI. We have provided source data as a separate Source Data file. The atomic coordinates and structure factors were deposited in the Protein Data Bank (PDB) under accession code 9DGJ (m6AMP) and DOI: 10.2210/pdb9dgj/pdb. The start files and the trajectories from molecular dynamics simulations can be downloaded from <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.12681486">https://doi.org/10.5281/zenodo.12681486</ext-link>. Requests for additional material and information should be directly addressed to Y.K.G. (<email xlink:href="mailto:guptay@uthscsa.edu">guptay@uthscsa.edu</email>).</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>This work was supported by the Welch Foundation (AQ-2101-) and, in part, by funding from NIH/NIAID (R01AI161363) to Y.K.G. C.V. is supported by an NIH T32 training grant (T32HL007446). S.F.M. is supported by the Cancer Prevention and Research Institute of Texas (RP210208). GM/CA at APS has been funded by the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006, P30GM138396). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bokar</surname>, <given-names>J.A.</given-names></string-name>, <string-name><surname>Rath-Shambaugh</surname>, <given-names>M.E.</given-names></string-name>, <string-name><surname>Ludwiczak</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Narayan</surname>, <given-names>P.</given-names></string-name> &amp; <string-name><surname>Roftman</surname>, <given-names>F.</given-names></string-name></person-group> <article-title>Characterizafion and parfial purificafion of mRNA N6-adenosine methyltransferase from HeLa cell nuclei. Internal mRNA methylafion requires a mulfisubunit complex</article-title>. <source>J Biol Chem</source> <volume>269</volume>, <fpage>17697</fpage>–<lpage>704</lpage> (<year>1994</year>).</mixed-citation></ref>
<ref id="ref2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Roftman</surname>, <given-names>F.M.</given-names></string-name>, <string-name><surname>Bokar</surname>, <given-names>J.A.</given-names></string-name>, <string-name><surname>Narayan</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Shambaugh</surname>, <given-names>M.E.</given-names></string-name> &amp; <string-name><surname>Ludwiczak</surname>, <given-names>R.</given-names></string-name></person-group> <article-title>N6-adenosine methylafion in mRNA: substrate specificity and enzyme complexity</article-title>. <source>Biochimie</source> <volume>76</volume>, <fpage>1109</fpage>–<lpage>14</lpage> (<year>1994</year>).</mixed-citation></ref>
<ref id="ref3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meyer</surname>, <given-names>K.D.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Comprehensive analysis of mRNA methylafion reveals enrichment in 3’ UTRs and near stop codons</article-title>. <source>Cell</source> <volume>149</volume>, <fpage>1635</fpage>–<lpage>46</lpage> (<year>2012</year>).</mixed-citation></ref>
<ref id="ref4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname>, <given-names>J.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylafion</article-title>. <source>Nat Chem Biol</source> <volume>10</volume>, <fpage>93</fpage>–<lpage>5</lpage> (<year>2014</year>).</mixed-citation></ref>
<ref id="ref5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dominissini</surname>, <given-names>D.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq</article-title>. <source>Nature</source> <volume>485</volume>, <fpage>201</fpage>–<lpage>6</lpage> (<year>2012</year>).</mixed-citation></ref>
<ref id="ref6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname>, <given-names>J.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>N (6)-methyladenosine of chromosome-associated regulatory RNA regulates chromafin state and transcripfion</article-title>. <source>Science</source> <volume>367</volume>, <fpage>580</fpage>–<lpage>586</lpage> (<year>2020</year>).</mixed-citation></ref>
<ref id="ref7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ke</surname>, <given-names>S.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>m(6)A mRNA modificafions are deposited in nascent pre-mRNA and are not required for splicing but do specify cytoplasmic turnover</article-title>. <source>Genes Dev</source> <volume>31</volume>, <fpage>990</fpage>–<lpage>1006</lpage> (<year>2017</year>).</mixed-citation></ref>
<ref id="ref8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Perez-Pepe</surname>, <given-names>M.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>7SK methylafion by METTL3 promotes transcripfional acfivity</article-title>. <source>Sci Adv</source> <volume>9</volume>, <fpage>eade7500</fpage> (<year>2023</year>).</mixed-citation></ref>
<ref id="ref9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bokar</surname>, <given-names>J.A.</given-names></string-name>, <string-name><surname>Shambaugh</surname>, <given-names>M.E.</given-names></string-name>, <string-name><surname>Polayes</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Matera</surname>, <given-names>A.G.</given-names></string-name> &amp; <string-name><surname>Roftman</surname>, <given-names>F.M.</given-names></string-name></person-group> <article-title>Purificafion and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)-methyltransferase</article-title>. <source>RNA</source> <volume>3</volume>, <fpage>1233</fpage>–<lpage>47</lpage> (<year>1997</year>).</mixed-citation></ref>
<ref id="ref10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bujnicki</surname>, <given-names>J.M.</given-names></string-name>, <string-name><surname>Feder</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Radlinska</surname>, <given-names>M.</given-names></string-name> &amp; <string-name><surname>Blumenthal</surname>, <given-names>R.M.</given-names></string-name></person-group> <article-title>Structure predicfion and phylogenefic analysis of a funcfionally diverse family of proteins homologous to the MT-A70 subunit of the human mRNA:m(6)A methyltransferase</article-title>. <source>J Mol Evol</source> <volume>55</volume>, <fpage>431</fpage>–<lpage>44</lpage> (<year>2002</year>).</mixed-citation></ref>
<ref id="ref11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Woodcock</surname>, <given-names>C.B.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Human MeftL3-MeftL14 complex is a sequence-specific DNA adenine methyltransferase acfive on single-strand and unpaired DNA in vitro</article-title>. <source>Cell Discov</source> <volume>5</volume>, <fpage>63</fpage> (<year>2019</year>).</mixed-citation></ref>
<ref id="ref12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Qi</surname>, <given-names>S.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>RNA binding to human METTL3-METTL14 restricts N(6)-deoxyadenosine methylafion of DNA in vitro</article-title>. <source>eLife</source> <volume>11</volume>. <year>2022</year></mixed-citation></ref>
<ref id="ref13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Woodcock</surname>, <given-names>C.B.</given-names></string-name>, <string-name><surname>Horton</surname>, <given-names>J.R.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Blumenthal</surname>, <given-names>R.M.</given-names></string-name> &amp; <string-name><surname>Cheng</surname>, <given-names>X.</given-names></string-name></person-group> <article-title>Beta class amino methyltransferases from bacteria to humans: evolufion and structural consequences</article-title>. <source>Nucleic Acids Res</source> <volume>48</volume>, <fpage>10034</fpage>–<lpage>10044</lpage> (<year>2020</year>).</mixed-citation></ref>
<ref id="ref14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>, <given-names>X.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Structural basis of N(6)-adenosine methylafion by the METTL3-METTL14 complex</article-title>. <source>Nature</source> <volume>534</volume>, <fpage>575</fpage>–<lpage>8</lpage> (<year>2016</year>).</mixed-citation></ref>
<ref id="ref15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Doxtader</surname>, <given-names>K.A.</given-names></string-name> &amp; <string-name><surname>Nam</surname>, <given-names>Y.</given-names></string-name></person-group> <article-title>Structural Basis for Cooperafive Funcfion of Meftl3 and Meftl14 Methyltransferases</article-title>. <source>Mol Cell</source> <volume>63</volume>, <fpage>306</fpage>–<lpage>17</lpage> (<year>2016</year>).</mixed-citation></ref>
<ref id="ref16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sledz</surname>, <given-names>P.</given-names></string-name> &amp; <string-name><surname>Jinek</surname>, <given-names>M.</given-names></string-name></person-group> <article-title>Structural insights into the molecular mechanism of the m(6)A writer complex</article-title>. <source>eLife</source> <volume>5</volume>. <year>2016</year></mixed-citation></ref>
<ref id="ref17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>, <given-names>Y.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>N6-methyladenosine modificafion destabilizes developmental regulators in embryonic stem cells</article-title>. <source>Nat Cell Biol</source> <volume>16</volume>, <fpage>191</fpage>–<lpage>8</lpage> (<year>2014</year>).</mixed-citation></ref>
<ref id="ref18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shi</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Wei</surname>, <given-names>J.</given-names></string-name> &amp; <string-name><surname>He</surname>, <given-names>C.</given-names></string-name></person-group> <article-title>Where, When, and How: Context-Dependent Funcfions of RNA Methylafion Writers, Readers, and Erasers</article-title>. <source>Mol Cell</source> <volume>74</volume>, <fpage>640</fpage>–<lpage>650</lpage> (<year>2019</year>).</mixed-citation></ref>
<ref id="ref19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Flamand</surname>, <given-names>M.N.</given-names></string-name>, <string-name><surname>Tegowski</surname>, <given-names>M.</given-names></string-name> &amp; <string-name><surname>Meyer</surname>, <given-names>K.D.</given-names></string-name></person-group> <article-title>The Proteins of mRNA Modificafion: Writers, Readers, and Erasers</article-title>. <source>Annu Rev Biochem</source> <volume>92</volume>, <fpage>145</fpage>–<lpage>173</lpage> (<year>2023</year>).</mixed-citation></ref>
<ref id="ref20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Geula</surname>, <given-names>S.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Stem cells. m6A mRNA methylafion facilitates resolufion of naive pluripotency toward differenfiafion</article-title>. <source>Science</source> <volume>347</volume>, <fpage>1002</fpage>–<lpage>6</lpage> (<year>2015</year>).</mixed-citation></ref>
<ref id="ref21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname>, <given-names>Y.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Meftl3-mediated m(6)A RNA methylafion regulates the fate of bone marrow mesenchymal stem cells and osteoporosis</article-title>. <source>Nat Commun</source> <volume>9</volume>, <fpage>4772</fpage> (<year>2018</year>).</mixed-citation></ref>
<ref id="ref22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>, <given-names>Y.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>N(6)-methyladenosine RNA modificafion regulates embryonic neural stem cell self-renewal through histone modificafions</article-title>. <source>Nat Neurosci</source> <volume>21</volume>, <fpage>195</fpage>–<lpage>206</lpage> (<year>2018</year>).</mixed-citation></ref>
<ref id="ref23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lin</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Choe</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Du</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Triboulet</surname>, <given-names>R.</given-names></string-name> &amp; <string-name><surname>Gregory</surname>, <given-names>R.I.</given-names></string-name></person-group> <article-title>The m(6)A Methyltransferase METTL3 Promotes Translafion in Human Cancer Cells</article-title>. <source>Mol Cell</source> <volume>62</volume>, <fpage>335</fpage>–<lpage>45</lpage> (<year>2016</year>).</mixed-citation></ref>
<ref id="ref24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Barbieri</surname>, <given-names>I.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Promoter-bound METTL3 maintains myeloid leukaemia by m(6)A-dependent translafion control</article-title>. <source>Nature</source> <volume>552</volume>, <fpage>126</fpage>–<lpage>131</lpage> (<year>2017</year>).</mixed-citation></ref>
<ref id="ref25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Choe</surname>, <given-names>J.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>mRNA circularizafion by METTL3-eIF3h enhances translafion and promotes oncogenesis</article-title>. <source>Nature</source> <volume>561</volume>, <fpage>556</fpage>–<lpage>560</lpage> (<year>2018</year>).</mixed-citation></ref>
<ref id="ref26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yankova</surname>, <given-names>E.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Small-molecule inhibifion of METTL3 as a strategy against myeloid leukaemia</article-title>. <source>Nature</source> <volume>593</volume>, <fpage>597</fpage>–<lpage>601</lpage> (<year>2021</year>).</mixed-citation></ref>
<ref id="ref27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McFadden</surname>, <given-names>M.J.</given-names></string-name> &amp; <string-name><surname>Horner</surname>, <given-names>S.M.</given-names></string-name></person-group> <article-title>N(6)-Methyladenosine Regulates Host Responses to Viral Infecfion</article-title>. <source>Trends Biochem Sci</source> <volume>46</volume>, <fpage>366</fpage>–<lpage>377</lpage> (<year>2021</year>).</mixed-citation></ref>
<ref id="ref28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Burgess</surname>, <given-names>H.M.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Targefing the m(6)A RNA modificafion pathway blocks SARS-CoV-2 and HCoV-OC43 replicafion</article-title>. <source>Genes Dev</source> <volume>35</volume>, <fpage>1005</fpage>–<lpage>1019</lpage> (<year>2021</year>).</mixed-citation></ref>
<ref id="ref29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>, <given-names>N.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>METTL3 regulates viral m6A RNA modificafion and host cell innate immune responses during SARS-CoV-2 infecfion</article-title>. <source>Cell Rep</source> <volume>35</volume>, <fpage>109091</fpage> (<year>2021</year>).</mixed-citation></ref>
<ref id="ref30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vu</surname>, <given-names>L.P.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differenfiafion of normal hematopoiefic and leukemia cells</article-title>. <source>Nat Med</source> (<year>2017</year>).</mixed-citation></ref>
<ref id="ref31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schumann</surname>, <given-names>U.</given-names></string-name>, <string-name><surname>Shafik</surname>, <given-names>A.</given-names></string-name> &amp; <string-name><surname>Preiss</surname>, <given-names>T.</given-names></string-name></person-group> <article-title>METTL3 Gains R/W Access to the Epitranscriptome</article-title>. <source>Mol Cell</source> <volume>62</volume>, <fpage>323</fpage>–<lpage>324</lpage> (<year>2016</year>).</mixed-citation></ref>
<ref id="ref32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Forbes</surname>, <given-names>S.A.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>COSMIC: exploring the world’s knowledge of somafic mutafions in human cancer</article-title>. <source>Nucleic Acids Res</source> <volume>43</volume>, <fpage>D805</fpage>–<lpage>11</lpage> (<year>2015</year>).</mixed-citation></ref>
<ref id="ref33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname>, <given-names>J.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>m(6)A mRNA methylafion regulates AKT acfivity to promote the proliferafion and tumorigenicity of endometrial cancer</article-title>. <source>Nat Cell Biol</source> <volume>20</volume>, <fpage>1074</fpage>–<lpage>1083</lpage> (<year>2018</year>).</mixed-citation></ref>
<ref id="ref34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Coots</surname>, <given-names>R.A.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>m(6)A Facilitates eIF4F-Independent mRNA Translafion</article-title>. <source>Mol Cell</source> <volume>68</volume>, <fpage>504</fpage>–<lpage>514 e7</lpage> (<year>2017</year>).</mixed-citation></ref>
<ref id="ref35"><label>35</label><mixed-citation publication-type="preprint"><person-group person-group-type="author"><string-name><surname>Zhang</surname>, <given-names>C.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Cancer mutafions rewire the RNA methylafion specificity of METTL3-METTL14</article-title>. <source>bioRxiv</source> (<year>2023</year>).</mixed-citation></ref>
<ref id="ref36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Luo</surname>, <given-names>Q.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Structural insights into molecular mechanism for N(6)-adenosine methylafion by MT-A70 family methyltransferase METTL4</article-title>. <source>Nat Commun</source> <volume>13</volume>, <fpage>5636</fpage> (<year>2022</year>).</mixed-citation></ref>
<ref id="ref37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gupta</surname>, <given-names>Y.K.</given-names></string-name>, <string-name><surname>Chan</surname>, <given-names>S.H.</given-names></string-name>, <string-name><surname>Xu</surname>, <given-names>S.Y.</given-names></string-name> &amp; <string-name><surname>Aggarwal</surname>, <given-names>A.K.</given-names></string-name></person-group> <article-title>Structural basis of asymmetric DNA methylafion and ATP-triggered long-range diffusion by EcoP15I</article-title>. <source>Nat Commun</source> <volume>6</volume>, <fpage>7363</fpage> (<year>2015</year>).</mixed-citation></ref>
<ref id="ref38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>, <given-names>X.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Structural insights into FTO’s catalyfic mechanism for the demethylafion of mulfiple RNA substrates</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>116</volume>, <fpage>2919</fpage>–<lpage>2924</lpage> (<year>2019</year>).</mixed-citation></ref>
<ref id="ref39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mauer</surname>, <given-names>J.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Reversible methylafion of m(6)A(m) in the 5’ cap controls mRNA stability</article-title>. <source>Nature</source> <volume>541</volume>, <fpage>371</fpage>–<lpage>375</lpage> (<year>2017</year>).</mixed-citation></ref>
<ref id="ref40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xu</surname>, <given-names>C.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Structural basis for selecfive binding of m6A RNA by the YTHDC1 YTH domain</article-title>. <source>Nat Chem Biol</source> <volume>10</volume>, <fpage>927</fpage>–<lpage>9</lpage> (<year>2014</year>).</mixed-citation></ref>
<ref id="ref41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Allan</surname>, <given-names>B.W.</given-names></string-name> &amp; <string-name><surname>Reich</surname>, <given-names>N.O.</given-names></string-name></person-group> <article-title>Targeted base stacking disrupfion by the EcoRI DNA methyltransferase</article-title>. <source>Biochemistry</source> <volume>35</volume>, <fpage>14757</fpage>–<lpage>62</lpage> (<year>1996</year>).</mixed-citation></ref>
<ref id="ref42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hamdane</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Guelorget</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Guerineau</surname>, <given-names>V.</given-names></string-name> &amp; <string-name><surname>Golinelli-Pimpaneau</surname>, <given-names>B.</given-names></string-name></person-group> <article-title>Dynamics of RNA modificafion by a mulfi-site-specific tRNA methyltransferase</article-title>. <source>Nucleic Acids Res</source> <volume>42</volume>, <fpage>11697</fpage>–<lpage>706</lpage> (<year>2014</year>).</mixed-citation></ref>
<ref id="ref43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Smart</surname>, <given-names>O.S.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>Validafion of ligands in macromolecular structures determined by X-ray crystallography</article-title>. <source>Acta Crystallogr D Struct Biol</source> <volume>74</volume>, <fpage>228</fpage>–<lpage>236</lpage> (<year>2018</year>).</mixed-citation></ref>
<ref id="ref44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Corbeski</surname>, <given-names>I.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>The catalyfic mechanism of the RNA methyltransferase METTL3</article-title>. <source>eLife</source> <volume>12</volume>. <year>2024</year></mixed-citation></ref>
<ref id="ref45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Adams</surname>, <given-names>P.D.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>PHENIX: a comprehensive Python-based system for macromolecular structure solufion</article-title>. <source>Acta Crystallogr D Biol Crystallogr</source> <volume>66</volume>, <fpage>213</fpage>–<lpage>21</lpage> (<year>2010</year>).</mixed-citation></ref>
<ref id="ref46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Emsley</surname>, <given-names>P.</given-names></string-name> &amp; <string-name><surname>Cowtan</surname>, <given-names>K.</given-names></string-name></person-group> <article-title>Coot: model-building tools for molecular graphics</article-title>. <source>Acta Crystallogr D Biol Crystallogr</source> <volume>60</volume>, <fpage>2126</fpage>–<lpage>32</lpage> (<year>2004</year>).</mixed-citation></ref>
<ref id="ref47"><label>47</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Bricogne</surname> <given-names>G.B.E.</given-names></string-name>, <string-name><surname>Brandl</surname> <given-names>M.</given-names></string-name>, <string-name><surname>Flensburg</surname> <given-names>C.</given-names></string-name>, <string-name><surname>Keller</surname> <given-names>P.</given-names></string-name>, <string-name><surname>Paciorek</surname> <given-names>W.</given-names></string-name>, &amp; <string-name><surname>Roversi P</surname>, <given-names>S.A.</given-names></string-name>, <string-name><surname>Smart</surname> <given-names>O.S.</given-names></string-name>, <string-name><surname>Vonrhein</surname> <given-names>C.</given-names></string-name>, <string-name><surname>Womack</surname> <given-names>T.O</given-names></string-name></person-group>. <source>BUSTER version 2.10.4</source>. <publisher-loc>Cambridge, United Kingdom</publisher-loc>: <publisher-name>Global Phasing Ltd</publisher-name>. (<year>2017</year>).</mixed-citation></ref>
<ref id="ref48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Marfinez-Rosell</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Giorgino</surname>, <given-names>T.</given-names></string-name> &amp; <string-name><surname>De Fabrifiis</surname>, <given-names>G.</given-names></string-name></person-group> <article-title>PlayMolecule ProteinPrepare: A Web Applicafion for Protein Preparafion for Molecular Dynamics Simulafions</article-title>. <source>J Chem Inf Model</source> <volume>57</volume>, <fpage>1511</fpage>–<lpage>1516</lpage> (<year>2017</year>).</mixed-citation></ref>
<ref id="ref49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Maier</surname>, <given-names>J.A.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB</article-title>. <source>J Chem Theory Comput</source> <volume>11</volume>, <fpage>3696</fpage>–<lpage>713</lpage> (<year>2015</year>).</mixed-citation></ref>
<ref id="ref50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Case</surname>, <given-names>D.A.</given-names></string-name> <etal>et al.</etal></person-group> <article-title>AmberTools</article-title>. <source>J Chem Inf Model</source> <volume>63</volume>, <fpage>6183</fpage>–<lpage>6191</lpage> (<year>2023</year>).</mixed-citation></ref>
<ref id="ref51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Kollman</surname>, <given-names>P.A.</given-names></string-name> &amp; <string-name><surname>Case</surname>, <given-names>D.A.</given-names></string-name></person-group> <article-title>Automafic atom type and bond type percepfion in molecular mechanical calculafions</article-title>. <source>J Mol Graph Model</source> <volume>25</volume>, <fpage>247</fpage>–<lpage>60</lpage> (<year>2006</year>).</mixed-citation></ref>
<ref id="ref52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hoover</surname>, <given-names>W.G.</given-names></string-name>, <string-name><surname>Ladd</surname>, <given-names>A.J.C.</given-names></string-name> &amp; <string-name><surname>Moran</surname>, <given-names>B.</given-names></string-name></person-group> <article-title>High-Strain-Rate Plasfic Flow Studied via Nonequilibrium Molecular Dynamics</article-title>. <source>Physical Review Lefters</source> <volume>48</volume>, <fpage>1818</fpage>–<lpage>1820</lpage> (<year>1982</year>).</mixed-citation></ref>
<ref id="ref53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cerufti</surname>, <given-names>D.S.</given-names></string-name>, <string-name><surname>Duke</surname>, <given-names>R.E.</given-names></string-name>, <string-name><surname>Darden</surname>, <given-names>T.A.</given-names></string-name> &amp; <string-name><surname>Lybrand</surname>, <given-names>T.P.</given-names></string-name></person-group> <article-title>Staggered Mesh Ewald: An extension of the Smooth Parficle-Mesh Ewald method adding great versafility</article-title>. <source>J Chem Theory Comput</source> <volume>5</volume>, <fpage>2322</fpage> (<year>2009</year>).</mixed-citation></ref>
<ref id="ref54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hess</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Bekker</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Berendsen</surname>, <given-names>H.J.C.</given-names></string-name> &amp; <string-name><surname>Fraaije</surname>, <given-names>J.G.E.M.</given-names></string-name></person-group> <article-title>LINCS: A linear constraint solver for molecular simulafions</article-title>. <source>Journal of Computafional Chemistry</source> <volume>18</volume>, <fpage>1463</fpage>–<lpage>1472</lpage> (<year>1997</year>).</mixed-citation></ref>
<ref id="ref55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Doerr</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Harvey</surname>, <given-names>M.J.</given-names></string-name>, <string-name><surname>Noé</surname>, <given-names>F.</given-names></string-name> &amp; <string-name><surname>De Fabrifiis</surname>, <given-names>G.</given-names></string-name></person-group> <article-title>HTMD: High-Throughput Molecular Dynamics for Molecular Discovery</article-title>. <source>Journal of Chemical Theory and Computafion</source> <volume>12</volume>, <fpage>1845</fpage>–<lpage>1852</lpage> (<year>2016</year>).</mixed-citation></ref>
<ref id="ref56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sabbadin</surname>, <given-names>D.</given-names></string-name> &amp; <string-name><surname>Moro</surname>, <given-names>S.</given-names></string-name></person-group> <article-title>Supervised Molecular Dynamics (SuMD) as a Helpful Tool To Depict GPCR–Ligand Recognifion Pathway in a Nanosecond Time Scale</article-title>. <source>Journal of Chemical Informafion and Modeling</source> <volume>54</volume>, <fpage>372</fpage>–<lpage>376</lpage> (<year>2014</year>).</mixed-citation></ref>
<ref id="ref57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Humphrey</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Dalke</surname>, <given-names>A.</given-names></string-name> &amp; <string-name><surname>Schulten</surname>, <given-names>K.</given-names></string-name></person-group> <article-title>VMD: visual molecular dynamics</article-title>. <source>J Mol Graph</source> <volume>14</volume>, <fpage>33</fpage>–<lpage>8</lpage>, <fpage>27</fpage>–<lpage>8</lpage> (<year>1996</year>).</mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.104909.1.sa2</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Roche</surname>
<given-names>Julien</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/04rswrd78</institution-id><institution>Iowa State University</institution>
</institution-wrap>
<city>Ames</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Solid</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Valuable</kwd>
</kwd-group>
</front-stub>
<body>
<p>The manuscript by Qi et al. provides <bold>valuable</bold> insights into the structural basis of RNA methylation by the METTL3-METTL14 complex, revealing a novel cryptic pocket critical for m6A recognition. The <bold>solid</bold> experimental approach, integrating crystallography, molecular simulations, and functional assays, supports a proposed two-step mechanism for enzymatic activity. Refining structural data and addressing binding kinetic inconsistencies would further enhance clarity and impact. This manuscript will interest researchers in RNA modification, cancer biology, and therapeutic drug development.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.104909.1.sa1</article-id>
<title-group>
<article-title>Reviewer #1 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>In this manuscript submitted by Qi et al., the authors study the RNA methylation mechanism by the METTL3-METTL14 complex. This complex catalyzes the major epitranscriptome methylation mark of nuclear RNA, including mRNA and lncRNAs. They catalyze the transfer of methyl group from SAM to convert the N6 of adenosine in RNA to m6A. Mutations in this complex have been associated with several diseases, such as type 2 diabetes and several types of cancer. The primary focus of this study was to understand the post-catalytic state of the METTL3-14 bound to a structural mimic of a reaction product known as N6-methyladenosine monophosphate (m6A) using X-ray crystallography. The authors show that the m6A occupies a novel pocket at the interface of the METTL3-14 complex and identified that residues interacting with m6A are mutated in several cancers. Furthermore, the authors demonstrate that the mutations lead to a significant loss in catalytic activity, alter RNA binding, and hinder the proper positioning of the substrate adenine in the active site. Lastly, the authors perform supervised molecular dynamics simulations to understand the effect of the mutations on the interaction network with m6A. The evidence for this study is good, with the combination of X-ray, functional assays, and molecular dynamics justifying their overall conclusions. This structure is significant as it provides new insights into the structural determinants of known cancer-associated mutations of this important class of enzymes. However, some issues need to be addressed.</p>
<p>Strengths:</p>
<p>(1) The X-ray structure is well determined, and the density map has the quality to observe all the interactions of the METTL3-14 complex with m6A.</p>
<p>(2) The structure reveals a novel 'cryptic pocket' in the complex that is 16 Å away from the SAM binding site. It is a functional m6A-sensor, illustrating a mechanism where the complex switches its functionality from an m6A writer to a reader.</p>
<p>(3) The structure illustrates that the residues forming cryptic pockets are found in multiple Cancer-associated mutations and are well conserved across several organisms.</p>
<p>(4) The functional assays (methyl transferase, RNA binding, kinetic, and SPR assays) provide a complete picture of the effect of the mutations on the activity of the METTL3-14 complex.</p>
<p>(5) Molecular dynamics simulations were done to understand the impact of the mutations on the pocket structure and its dynamics and support the X-ray structure findings.</p>
<p>Weaknesses:</p>
<p>(1) Although the X-ray structure is well determined, the statistics are a bit troubling, particularly the Ramachandran, Sidechain and RSRZ outliers. It is well above the average for structures at that resolution. Maybe the use of alternative software such as ISOLDE may be adequate to improve those parameters.</p>
<p>(2) The authors should expand their discussion as to why the affinity for the product is higher than the substrate and the implications on the mechanism.</p>
<p>(3) The SPR profiles of the association kinetics look to have several minor association-dissociation events occurring. Multiple binding sites? Authors should provide an explanation for such behavior. Also, what is the structural explanation of the difference in binding modes between the wt vs. mutant (one vs. two-state binding modes)?</p>
<p>(4) In materials and methods, it shows the data in Figure 2a was fitted to a Michaelis-Menten equation, however, the Y axis shows Normalized methylation and not initial rates. The authors should elaborate on their approach. In addition, more than three initial velocity rate points per protein are needed to fit a Michaelis-Menten curve confidently. Additionally, where can the Michaelis-Menten parameters be found?</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.104909.1.sa0</article-id>
<title-group>
<article-title>Reviewer #2 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>Qi et al. determined the X-ray crystallographic structure of the methyltransferase core of the obligate heterodimeric complex METTL3-METTL14 in complex with methyladenosine monophosphate (m6A), a product mimic for the methylation of adenosine, to a resolution of 2.5 Å. Their structure appears to reveal a cryptic binding pocket for m6A that had not previously been identified. Using full-length protein produced in insect cells, Qi et al. determined the methyltransferase activity of wildtype METTL3-METTL14 and compared it to that of mutant forms of the protein that have been implicated in cancer. In addition to methyltransferase activity, the authors used both fluorescence polarization assays and surface plasmon resonance to investigate the affinities and kinetics of RNA binding to wildtype and mutant forms of the full-length complex. The results indicate that mutations in the methyltransferase core of two separate arginine residues alter the dynamics of RNA binding and enzyme specificity of METTL3-METTL14. The authors go on to use a combination of supervised molecular dynamics simulations and comparisons to recently published structures to propose a &quot;swivelling&quot; mechanism for the transfer of the methylated substrate from the catalytic site of the complex to the novel cryptic pocket.</p>
<p>Strengths:</p>
<p>I appreciated the inclusion of supplementary data showing the purity and monodispersity of the protein used for crystallization as well as the omit map and other electron density maps to support the placement of the product mimic in the cryptic site. The authors use a combination of complementary biophysical techniques to test the effects of mutations that were identified in the literature as being clinically important and to develop a hypothesis for the large-scale translocation required for the enzymatic product to move from the catalytic site to the cryptic pocket. The use of molecular dynamics simulations to attempt to indirectly visualize how this translocation might occur in vivo was well done.</p>
<p>Weaknesses:</p>
<p>Even taking into account the 2.5 Å resolution of the structure, the model is not refined to the point that it could be. Some waters seem to be built into blobs of density that aren't particularly convincing, and other seemingly obvious waters aren't built at all. The structure validation report supports this and shows that overall, and in the context of 2.5 Å resolution, this is not a great model. A good many parts of the structural analysis don't seem consistent with what I see when I look at the model and density in terms of proposed interactions in the cryptic pocket. Much of the language used in the manuscript is too strong when the model is quite speculative.</p>
</body>
</sub-article>
</article>